| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule motor activity | 1.94e-06 | 70 | 167 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.25e-06 | 49 | 167 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCB7 NSF DYNC2H1 KIF16B ABCB6 CHD9 DNAH7 ABCA10 KIF7 ABCB1 KIF3B ABCB10 MLH1 ABCC2 DNAH5 | 4.70e-06 | 441 | 167 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.78e-06 | 118 | 167 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 ABCB7 NSF DYNC2H1 KIF16B ABCB6 CHD9 DNAH7 ABCA10 KIF7 ABCB1 KIF3B ABCB10 MLH1 DYNC1LI1 ABCC2 DNAH5 | 1.62e-05 | 614 | 167 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCB7 NSF DYNC2H1 KIF16B ABCB6 CHD9 ARL9 DNAH7 ABCA10 KIF7 ABCB1 DRG1 RAB28 KIF3B ABCB10 EIF2S3 MLH1 ABCC2 DNAH5 | 2.73e-05 | 775 | 167 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCB7 NSF DYNC2H1 KIF16B ABCB6 CHD9 ARL9 DNAH7 ABCA10 KIF7 ABCB1 DRG1 RAB28 KIF3B ABCB10 EIF2S3 MLH1 ABCC2 DNAH5 | 7.92e-05 | 839 | 167 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCB7 NSF DYNC2H1 KIF16B ABCB6 CHD9 ARL9 DNAH7 ABCA10 KIF7 ABCB1 DRG1 RAB28 KIF3B ABCB10 EIF2S3 MLH1 ABCC2 DNAH5 | 8.04e-05 | 840 | 167 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCB7 NSF DYNC2H1 KIF16B ABCB6 CHD9 ARL9 DNAH7 ABCA10 KIF7 ABCB1 DRG1 RAB28 KIF3B ABCB10 EIF2S3 MLH1 ABCC2 DNAH5 | 8.04e-05 | 840 | 167 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | RANBP10 MYH9 ABL1 ANK3 SPTBN1 WASHC1 KIF16B RUSC1 GRIA1 RABGAP1 MAP3K1 HNRNPK KIF7 DRG1 CLIP4 SPTBN4 KIF3B EML5 PHACTR3 CNGA3 EPB41L2 MYBPC3 | 1.29e-04 | 1099 | 167 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 2.02e-04 | 35 | 167 | 4 | GO:0051019 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 2.43e-04 | 15 | 167 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 2.97e-04 | 16 | 167 | 3 | GO:0016812 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.11e-04 | 109 | 167 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.27e-04 | 18 | 167 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 7.61e-04 | 178 | 167 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.02e-03 | 24 | 167 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.02e-03 | 24 | 167 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 1.15e-03 | 25 | 167 | 3 | GO:0048027 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 1.42e-03 | 7 | 167 | 2 | GO:0016723 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.61e-03 | 28 | 167 | 3 | GO:0051959 | |
| GeneOntologyCellularComponent | supramolecular fiber | WHRN DPYSL2 MYH9 EPPK1 ANK3 DYNC2H1 SPTBN1 KIF16B RUSC1 DAPK3 FBP2 ARHGEF25 DNAH7 MAP3K1 RYR3 KIF7 CLIP4 SPTBN4 MTA1 KIF3B EML5 DYNC1LI1 PYGM DNAH5 MYBPC3 | 9.37e-06 | 1179 | 169 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | WHRN DPYSL2 MYH9 EPPK1 ANK3 DYNC2H1 SPTBN1 KIF16B RUSC1 DAPK3 FBP2 ARHGEF25 DNAH7 MAP3K1 RYR3 KIF7 CLIP4 SPTBN4 MTA1 KIF3B EML5 DYNC1LI1 PYGM DNAH5 MYBPC3 | 1.05e-05 | 1187 | 169 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 1.30e-05 | 96 | 169 | 7 | GO:0010494 | |
| GeneOntologyCellularComponent | spectrin | 4.21e-05 | 9 | 169 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | microtubule associated complex | 5.08e-05 | 161 | 169 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | WHRN DPYSL2 MYH9 EPPK1 DYNC2H1 KIF16B RUSC1 DAPK3 DNAH7 MAP3K1 KIF7 CLIP4 SPTBN4 MTA1 KIF3B EML5 DYNC1LI1 DNAH5 | 3.68e-04 | 899 | 169 | 18 | GO:0099513 |
| GeneOntologyCellularComponent | ribonucleoprotein granule | RPL28 HNRNPK KHSRP IGF2BP1 IGF2BP3 IGF2BP2 G3BP2 ENDOV SYMPK | 5.63e-04 | 287 | 169 | 9 | GO:0035770 |
| GeneOntologyCellularComponent | ciliary tip | 6.08e-04 | 48 | 169 | 4 | GO:0097542 | |
| Domain | KH_1 | 1.28e-09 | 38 | 166 | 8 | PF00013 | |
| Domain | - | 1.60e-09 | 39 | 166 | 8 | 3.30.1370.10 | |
| Domain | KH | 1.99e-09 | 40 | 166 | 8 | SM00322 | |
| Domain | KH_dom | 1.99e-09 | 40 | 166 | 8 | IPR004087 | |
| Domain | KH_TYPE_1 | 3.00e-09 | 42 | 166 | 8 | PS50084 | |
| Domain | KH_dom_type_1 | 4.44e-09 | 44 | 166 | 8 | IPR004088 | |
| Domain | AAA | ABCB7 NSF DYNC2H1 ABCB6 DNAH7 ABCA10 ABCB1 ABCB10 ABCC2 DNAH5 | 6.47e-07 | 144 | 166 | 10 | SM00382 |
| Domain | AAA+_ATPase | ABCB7 NSF DYNC2H1 ABCB6 DNAH7 ABCA10 ABCB1 ABCB10 ABCC2 DNAH5 | 6.47e-07 | 144 | 166 | 10 | IPR003593 |
| Domain | ABC_transporter_CS | 1.81e-06 | 42 | 166 | 6 | IPR017871 | |
| Domain | ABC_membrane | 1.94e-06 | 24 | 166 | 5 | PF00664 | |
| Domain | ABC_tran | 4.06e-06 | 48 | 166 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.06e-06 | 48 | 166 | 6 | PS50893 | |
| Domain | ABC_TM1F | 4.35e-06 | 28 | 166 | 5 | PS50929 | |
| Domain | ABC1_TM_dom | 4.35e-06 | 28 | 166 | 5 | IPR011527 | |
| Domain | ABC_TRANSPORTER_1 | 4.59e-06 | 49 | 166 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 5.18e-06 | 50 | 166 | 6 | IPR003439 | |
| Domain | P-loop_NTPase | MYH9 ABCB7 NSF DYNC2H1 KIF16B ABCB6 CHD9 ARL9 DNAH7 ABCA10 KIF7 ABCB1 DRG1 RAB28 NWD2 KIF3B ABCB10 EIF2S3 DYNC1LI1 ABCC2 DNAH5 | 2.11e-05 | 848 | 166 | 21 | IPR027417 |
| Domain | DUF1897 | 7.85e-05 | 2 | 166 | 2 | PF09005 | |
| Domain | DUF1897 | 7.85e-05 | 2 | 166 | 2 | IPR015096 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.34e-04 | 14 | 166 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.34e-04 | 14 | 166 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.34e-04 | 14 | 166 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.34e-04 | 14 | 166 | 3 | PF08393 | |
| Domain | MT | 2.34e-04 | 14 | 166 | 3 | PF12777 | |
| Domain | AAA_8 | 2.34e-04 | 14 | 166 | 3 | PF12780 | |
| Domain | DHC_fam | 2.90e-04 | 15 | 166 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.90e-04 | 15 | 166 | 3 | PF03028 | |
| Domain | PI3/4_kinase_CS | 2.90e-04 | 15 | 166 | 3 | IPR018936 | |
| Domain | Dynein_heavy_dom | 2.90e-04 | 15 | 166 | 3 | IPR004273 | |
| Domain | - | 3.55e-04 | 16 | 166 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.55e-04 | 16 | 166 | 3 | SM00146 | |
| Domain | - | ABCB7 NSF DYNC2H1 ABCB6 CHD9 ARL9 DNAH7 ABCA10 ABCB1 DRG1 RAB28 NWD2 ABCB10 EIF2S3 DYNC1LI1 ABCC2 DNAH5 | 3.59e-04 | 746 | 166 | 17 | 3.40.50.300 |
| Domain | PPIase_FKBP | 4.28e-04 | 17 | 166 | 3 | IPR023566 | |
| Domain | - | 4.66e-04 | 4 | 166 | 2 | 3.90.1460.10 | |
| Domain | Spectrin_bsu | 4.66e-04 | 4 | 166 | 2 | IPR016343 | |
| Domain | GTF2I | 4.66e-04 | 4 | 166 | 2 | PS51139 | |
| Domain | GTF2I | 4.66e-04 | 4 | 166 | 2 | PF02946 | |
| Domain | GTF2I | 4.66e-04 | 4 | 166 | 2 | IPR004212 | |
| Domain | PI3_PI4_kinase | 5.10e-04 | 18 | 166 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.10e-04 | 18 | 166 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.10e-04 | 18 | 166 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.10e-04 | 18 | 166 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.10e-04 | 18 | 166 | 3 | PS50290 | |
| Domain | PPIase_FKBP_dom | 7.03e-04 | 20 | 166 | 3 | IPR001179 | |
| Domain | LCCL | 1.15e-03 | 6 | 166 | 2 | PS50820 | |
| Domain | LCCL | 1.15e-03 | 6 | 166 | 2 | SM00603 | |
| Domain | LCCL | 1.15e-03 | 6 | 166 | 2 | PF03815 | |
| Domain | LCCL | 1.15e-03 | 6 | 166 | 2 | IPR004043 | |
| Domain | - | 1.15e-03 | 6 | 166 | 2 | 2.170.130.20 | |
| Domain | PDZ | 1.64e-03 | 141 | 166 | 6 | PF00595 | |
| Domain | PDZ | 2.10e-03 | 148 | 166 | 6 | SM00228 | |
| Domain | DHC_N1 | 2.12e-03 | 8 | 166 | 2 | PF08385 | |
| Domain | PI3K_C2 | 2.12e-03 | 8 | 166 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 2.12e-03 | 8 | 166 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 2.12e-03 | 8 | 166 | 2 | PF00792 | |
| Domain | - | 2.12e-03 | 8 | 166 | 2 | 2.30.40.10 | |
| Domain | PI3K_C2 | 2.12e-03 | 8 | 166 | 2 | PS51547 | |
| Domain | Dynein_heavy_dom-1 | 2.12e-03 | 8 | 166 | 2 | IPR013594 | |
| Domain | - | 2.25e-03 | 150 | 166 | 6 | 2.30.42.10 | |
| Domain | PDZ | 2.32e-03 | 151 | 166 | 6 | PS50106 | |
| Domain | PDZ | 2.40e-03 | 152 | 166 | 6 | IPR001478 | |
| Domain | - | SPTBN1 PHLDA3 RABGAP1 ARHGEF11 ARHGEF25 SPTBN4 PTPN13 ARHGAP21 EPB41L2 GULP1 | 2.66e-03 | 391 | 166 | 10 | 2.30.29.30 |
| Domain | PI3Ka | 2.71e-03 | 9 | 166 | 2 | PF00613 | |
| Domain | PH_dom-spectrin-type | 2.71e-03 | 9 | 166 | 2 | IPR001605 | |
| Domain | PI3Ka | 2.71e-03 | 9 | 166 | 2 | SM00145 | |
| Domain | - | 2.71e-03 | 9 | 166 | 2 | 1.25.40.70 | |
| Domain | CNMP_BINDING_1 | 2.83e-03 | 32 | 166 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.83e-03 | 32 | 166 | 3 | PS00889 | |
| Domain | cNMP | 3.37e-03 | 34 | 166 | 3 | SM00100 | |
| Domain | cNMP_binding | 3.37e-03 | 34 | 166 | 3 | PF00027 | |
| Domain | Amidohydro_1 | 3.37e-03 | 10 | 166 | 2 | PF01979 | |
| Domain | PI_Kinase | 3.37e-03 | 10 | 166 | 2 | IPR015433 | |
| Domain | Metal-dep_hydrolase_composite | 3.37e-03 | 10 | 166 | 2 | IPR011059 | |
| Domain | PInositide-3_kin_accessory_dom | 3.37e-03 | 10 | 166 | 2 | IPR001263 | |
| Domain | PIK_HELICAL | 3.37e-03 | 10 | 166 | 2 | PS51545 | |
| Domain | Kinase-like_dom | ABL1 CHD9 DAPK3 MAP3K1 PTPN13 PIK3C2A PIK3C3 GUCY2D MAPKAPK3 MAP3K10 PRKDC PRKG2 | 3.37e-03 | 542 | 166 | 12 | IPR011009 |
| Domain | ARM-type_fold | 3.37e-03 | 339 | 166 | 9 | IPR016024 | |
| Domain | cNMP-bd_dom | 3.66e-03 | 35 | 166 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 3.66e-03 | 35 | 166 | 3 | PS50042 | |
| Domain | Elongated_TPR_rpt_dom | 4.10e-03 | 11 | 166 | 2 | IPR023114 | |
| Domain | Amidohydro-rel | 4.10e-03 | 11 | 166 | 2 | IPR006680 | |
| Domain | cNMP-bd-like | 4.63e-03 | 38 | 166 | 3 | IPR018490 | |
| Domain | PH_dom-like | SPTBN1 PHLDA3 RABGAP1 ARHGEF11 ARHGEF25 SPTBN4 PTPN13 ARHGAP21 EPB41L2 GULP1 | 4.87e-03 | 426 | 166 | 10 | IPR011993 |
| Domain | Kinesin_motor_CS | 5.74e-03 | 41 | 166 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 6.56e-03 | 43 | 166 | 3 | IPR027640 | |
| Domain | ATPase_dyneun-rel_AAA | 6.66e-03 | 14 | 166 | 2 | IPR011704 | |
| Domain | AAA_5 | 6.66e-03 | 14 | 166 | 2 | PF07728 | |
| Domain | - | 6.99e-03 | 44 | 166 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 6.99e-03 | 44 | 166 | 3 | PF00225 | |
| Domain | KISc | 6.99e-03 | 44 | 166 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 6.99e-03 | 44 | 166 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 6.99e-03 | 44 | 166 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 6.99e-03 | 44 | 166 | 3 | PS50067 | |
| Domain | cNMP-bd_CS | 8.68e-03 | 16 | 166 | 2 | IPR018488 | |
| Domain | FKBP_PPIASE | 8.68e-03 | 16 | 166 | 2 | PS50059 | |
| Domain | FKBP_C | 8.68e-03 | 16 | 166 | 2 | PF00254 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 4.13e-07 | 103 | 129 | 9 | M758 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.77e-06 | 44 | 129 | 6 | M11911 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.38e-05 | 99 | 129 | 7 | MM14986 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 9.24e-05 | 156 | 129 | 8 | M27097 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.21e-04 | 121 | 129 | 7 | M872 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.74e-04 | 31 | 129 | 4 | M877 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | MYH9 EPPK1 SRSF4 SRSF5 NSF SPTBN1 ELP1 UNC45A HNRNPK DRG1 EXOC5 GSDME KANSL1 FUBP1 G3BP2 MLH1 DYNC1LI1 PRKDC MVP SYMPK HDLBP GULP1 | 1.81e-13 | 582 | 172 | 22 | 20467437 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL28 DPYSL2 MYH9 EPPK1 SRSF4 SRSF5 ANK3 NSF SPTBN1 PSMD7 UNC45A DNAJB3 HNRNPK KHSRP DRG1 IGF2BP1 IGF2BP3 IGF2BP2 MTA1 FUBP1 EIF2S3 G3BP2 DYNC1LI1 MRPS5 PRKDC FKBP5 EPB41L2 SYMPK HDLBP | 5.42e-13 | 1149 | 172 | 29 | 35446349 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPL28 DPYSL2 BTF3L4 EDF1 MYH9 ZFYVE16 STXBP4 PSMD7 UNC45A HNRNPK KHSRP IGF2BP1 GTF2F2 IGF2BP3 IGF2BP2 PTPN13 EIF2S3 CIAPIN1 SEC23IP MLH1 EIF3C PRKDC ARHGAP21 SDCBP EPB41L2 HDLBP | 1.11e-12 | 934 | 172 | 26 | 33916271 |
| Pubmed | DPYSL2 UNC45A OSGEP SUCLG2 LARS2 TSFM DRG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 MTA1 RDH11 EIF2S3 EIF3C PRKDC NUP188 FUBP3 EPB41L2 HDLBP | 2.88e-12 | 534 | 172 | 20 | 35032548 | |
| Pubmed | RPL28 EDF1 MYH9 SRSF4 SRSF5 ACAT1 NSF CHD9 PSMD7 DNAH7 PSMA8 HNRNPK KHSRP DRG1 GTF2IRD2B FARSA IGF2BP1 IGF2BP3 IGF2BP2 MTA1 MRPL14 G3BP2 GTF2IRD2 DYNC1LI1 MRPS5 EIF3C PRKDC FKBP5 | 3.57e-12 | 1153 | 172 | 28 | 29845934 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL28 MYH9 SRSF5 ACAT1 NSF DYNC2H1 SPTBN1 ELP1 PSMD7 UNC45A TSFM HNRNPK KHSRP DRG1 FARSA IGF2BP1 RDH11 FUBP1 EIF2S3 G3BP2 SEC23IP DYNC1LI1 EIF3C PRKDC NUP188 DNAH5 FUBP3 PHIP SDCBP EPB41L2 HDLBP | 3.65e-12 | 1425 | 172 | 31 | 30948266 |
| Pubmed | RPL28 MYH9 ABCB7 ACAT1 NSF SPTBN1 HNRNPK KHSRP ABCB1 FARSA IGF2BP1 IGF2BP3 EIF2S3 SEC23IP EIF3C NUP188 FUBP3 SDCBP EPB41L2 | 4.64e-12 | 484 | 172 | 19 | 31995728 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPL28 DPYSL2 BTF3L4 MYH9 SRSF5 SPTBN1 ELP1 PSMD7 RABGAP1 UNC45A OSGEP HNRNPK KHSRP FARSA GTF2F2 IGF2BP3 FUBP1 EIF2S3 CIAPIN1 SEC23IP STRN4 DYNC1LI1 MTRR EIF3C PRKDC NUP188 MVP FUBP3 FKBP5 EPB41L2 HDLBP | 6.20e-12 | 1455 | 172 | 31 | 22863883 |
| Pubmed | RPL28 MYH9 SRSF4 ACAT1 SPTBN1 CHD9 PDHX HNRNPK KHSRP DRG1 FARSA IGF2BP1 IGF2BP3 FUBP1 EIF2S3 G3BP2 STRN4 DYNC1LI1 MRPS5 EIF3C PRKDC ARHGAP21 HDLBP | 1.65e-11 | 809 | 172 | 23 | 32129710 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL28 DPYSL2 MYH9 ACAT1 PKP4 SPTBN1 ELP1 PSMD7 UNC45A SUCLG2 HNRNPK KHSRP ARG1 IGF2BP2 PNPLA6 KANSL1 MRPL14 RDH11 PIK3C2A FUBP1 MLH1 DYNC1LI1 CAVIN1 PRKDC MVP FUBP3 PHIP EPB41L2 HDLBP | 2.84e-11 | 1353 | 172 | 29 | 29467282 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MIA3 ABCB7 SRSF4 ACAT1 MTRES1 KIF16B ELP1 DAPK3 PSMD7 RABGAP1 SUCLG2 LARS2 PDHX TSFM HNRNPK IGF2BP1 IGF2BP3 IGF2BP2 ABCB10 MRPL14 PIK3C2A FUBP1 SURF1 G3BP2 SEC23IP STRN4 MRPS5 NUP188 FUBP3 PHIP | 6.24e-11 | 1496 | 172 | 30 | 32877691 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | EDF1 MYH9 PPAN EPPK1 SRSF4 SRSF5 SPTBN1 TSFM HNRNPK KHSRP FARSA IGF2BP1 IGF2BP3 IGF2BP2 MRPL14 FUBP1 G3BP2 MRPS5 EIF3C PRKDC FUBP3 HDLBP | 1.05e-10 | 807 | 172 | 22 | 22681889 |
| Pubmed | MYH9 SRSF4 ACAT1 PKP4 SPTBN1 HNRNPK KHSRP IGF2BP1 IGF2BP3 FUBP1 EIF2S3 G3BP2 FUBP3 ARHGAP21 | 1.11e-10 | 274 | 172 | 14 | 34244482 | |
| Pubmed | RANBP10 EDF1 ABCB7 PPAN SRSF5 NSF SPTBN1 ELP1 PSMD7 UNC45A SUCLG2 KHSRP EXOC5 FARSA IGF2BP1 IGF2BP3 IGF2BP2 RDH11 PIK3C2A EIF2S3 G3BP2 DYNC1LI1 MRPS5 CAVIN1 EIF3C PRKDC NUP188 FUBP3 FKBP5 | 1.23e-10 | 1440 | 172 | 29 | 30833792 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL28 MYH9 PPAN SRSF4 ACAT1 NSF PSMD7 SUCLG2 PSMA8 TSFM HNRNPK RSRC1 KHSRP DRG1 RSBN1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 ABCB10 FUBP1 EIF2S3 MRPS5 PRKDC FUBP3 PHIP FKBP5 | 4.02e-10 | 1318 | 172 | 27 | 30463901 |
| Pubmed | RPL28 DPYSL2 MYH9 SRSF5 ANK3 ACAT1 NSF PKP4 SPTBN1 ELP1 GRIA1 DAPK3 ARHGEF11 PDHX HNRNPK KHSRP SPTBN4 FARSA NWD2 PNPLA6 EIF2S3 G3BP2 STRN4 EIF3C ARHGAP21 SDCBP EPB41L2 HDLBP | 5.12e-10 | 1431 | 172 | 28 | 37142655 | |
| Pubmed | RANBP10 RPL28 SRSF4 ZFYVE16 ACAT1 WASHC1 ELP1 PSMD7 PSMA8 HNRNPK KHSRP DRG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 POLR3D MTA1 MRPL14 G3BP2 MRPS5 EIF3C PRKDC NUP188 FUBP3 FKBP5 HDLBP | 5.31e-10 | 1335 | 172 | 27 | 29229926 | |
| Pubmed | RPL28 DPYSL2 MYH9 NSF SPTBN1 UNC45A HNRNPK ARG1 IGF2BP2 KIF3B RDH11 PRKDC MVP HDLBP | 6.06e-10 | 312 | 172 | 14 | 37120454 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | SRSF4 SRSF5 HNRNPK KHSRP IGF2BP1 IGF2BP3 IGF2BP2 FUBP1 G3BP2 MRPS5 EIF3C FUBP3 HDLBP | 6.22e-10 | 258 | 172 | 13 | 37794589 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RANBP10 RPL28 DPYSL2 SRSF4 SRSF5 ZFYVE16 NSF STXBP4 ELP1 PSMD7 UNC45A OSGEP FAAP100 HNRNPK KHSRP KIF7 IGF2BP1 IGF2BP2 EIF3C PRKDC NUP188 FUBP3 FKBP5 | 6.25e-10 | 974 | 172 | 23 | 28675297 |
| Pubmed | DPYSL2 MYH9 EPPK1 SRSF4 SRSF5 ACAT1 SPTBN1 ELP1 KHSRP IGF2BP3 IGF2BP2 PRKDC NUP188 MVP FUBP3 PHIP EPB41L2 SYMPK HDLBP | 7.38e-10 | 653 | 172 | 19 | 22586326 | |
| Pubmed | EDF1 MYH9 SRSF5 SPTBN1 ELP1 UNC45A SUCLG2 PSMA8 MAP3K1 TSFM RSRC1 KHSRP DRG1 RSBN1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 FBXO24 PIK3C2A G3BP2 CAVIN1 FUBP3 EPB41L2 CA3 CBX2 HDLBP | 9.45e-10 | 1371 | 172 | 27 | 36244648 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RPL28 MYH9 PPAN EPPK1 SRSF4 ACAT1 NSF PHLDA3 PSMD7 UNC45A OSGEP QRICH2 KHSRP IGF2BP1 IGF2BP3 IGF2BP2 PIK3C3 FUBP1 EIF2S3 G3BP2 STRN4 MRPS5 PYGM NUP188 EPB41L2 HDLBP | 1.12e-09 | 1284 | 172 | 26 | 17353931 |
| Pubmed | RPL28 MIA3 ABCB7 ANK3 NSF DYNC2H1 STXBP4 PKP4 SPTBN1 KIF16B ELP1 PSMD7 UNC45A DNAJB3 PDHX KIF7 DRG1 EXOC5 PTPN13 PNPLA6 ABCB10 PIK3C2A EIF2S3 MRPS5 IFT122 FKBP5 EPB41L2 HDLBP | 1.20e-09 | 1487 | 172 | 28 | 33957083 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL28 DPYSL2 MYH9 MIA3 SPTBN1 PSMD7 RABGAP1 SUCLG2 HNRNPK KHSRP IGF2BP1 GTF2F2 IGF2BP3 MTA1 FUBP1 EIF2S3 G3BP2 DYNC1LI1 EIF3C PRKDC EPB41L2 | 1.57e-09 | 847 | 172 | 21 | 35235311 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | EPPK1 ACAT1 NSF SPTBN1 SUCLG2 LARS2 DRG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 RDH11 FUBP1 EIF2S3 EIF3C FUBP3 EPB41L2 HDLBP | 1.58e-09 | 607 | 172 | 18 | 39147351 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL28 PPAN EPPK1 ACAT1 NSF ELP1 HNRNPK KHSRP KIF7 ABCB1 DRG1 ARG1 IGF2BP1 IGF2BP3 IGF2BP2 FUBP1 EIF3C PRKDC NUP188 FUBP3 PHIP EPB41L2 HDLBP | 1.62e-09 | 1024 | 172 | 23 | 24711643 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL28 BTF3L4 EDF1 MYH9 EPPK1 SRSF5 SPTBN1 ELP1 UNC45A HNRNPK RSRC1 KHSRP DRG1 FARSA IGF2BP1 GTF2F2 IGF2BP3 MRPL14 EIF2S3 G3BP2 MRPS5 CAVIN1 EIF3C PRKDC SDCBP EPB41L2 HDLBP | 1.86e-09 | 1415 | 172 | 27 | 28515276 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 ELP1 OSGEP SUCLG2 HNRNPK FARSA IGF2BP1 IGF2BP3 IGF2BP2 RDH11 EIF2S3 G3BP2 EIF3C PRKDC NUP188 DNAH5 FUBP3 FKBP5 EPB41L2 | 2.53e-09 | 704 | 172 | 19 | 29955894 |
| Pubmed | RANBP10 DPYSL2 MYH9 MIA3 ANK3 NSF PKP4 SPTBN1 GRIA1 DAPK3 ARHGEF11 HNRNPK KHSRP KIF7 SPTBN4 FARSA KIF3B G3BP2 SEC23IP STRN4 ARHGAP21 EPB41L2 | 2.79e-09 | 963 | 172 | 22 | 28671696 | |
| Pubmed | DPYSL2 MYH9 ABCB7 NSF HNRNPK KHSRP IGF2BP1 IGF2BP3 MTA1 FUBP1 G3BP2 PRKDC FUBP3 | 3.56e-09 | 298 | 172 | 13 | 30737378 | |
| Pubmed | RPL28 MYH9 ABCB7 SRSF5 NSF HNRNPK KHSRP DRG1 RSBN1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 ABCB10 EIF2S3 G3BP2 DYNC1LI1 PRKDC NUP188 | 4.07e-09 | 725 | 172 | 19 | 27025967 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DPYSL2 BTF3L4 EDF1 MYH9 SRSF4 SRSF5 SPTBN1 CHD9 HNRNPK KHSRP DRG1 ARG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 PTPN13 NWD2 DYNC1LI1 EIF3C PRKDC MVP SYMPK | 4.58e-09 | 1082 | 172 | 23 | 38697112 |
| Pubmed | RPL28 MYH9 PPAN SRSF4 SRSF5 SPTBN1 HNRNPK RSRC1 KHSRP ARG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 MRPL14 EIF2S3 MRPS5 EIF3C FUBP3 | 4.65e-09 | 731 | 172 | 19 | 29298432 | |
| Pubmed | BTF3L4 EDF1 ZNF174 CHD9 PSMD7 HNRNPK KHSRP DRG1 IGF2BP1 GTF2F2 IGF2BP3 IGF2BP2 MTA1 FUBP1 EIF2S3 G3BP2 CIAPIN1 DYNC1LI1 PRKDC FUBP3 FKBP5 SDCBP HDLBP | 6.55e-09 | 1103 | 172 | 23 | 34189442 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | RPL28 MYH9 SPTBN1 ARHGEF11 MAP3K1 HNRNPK IGF2BP1 IGF2BP2 PIK3C2A G3BP2 CNGA3 ARHGAP21 HDLBP | 7.46e-09 | 317 | 172 | 13 | 17620599 |
| Pubmed | RPL28 ACAT1 PDHX HNRNPK KHSRP DRG1 EXOC5 IGF2BP1 IGF2BP3 IGF2BP2 EIF2S3 FUBP3 HDLBP | 7.46e-09 | 317 | 172 | 13 | 30997501 | |
| Pubmed | RPL28 DPYSL2 MYH9 EPPK1 ANK3 PKP4 PSMA8 MAP3K1 HNRNPK KHSRP ARG1 FARSA IGF2BP2 FUBP1 PHACTR3 PYGM EIF3C PRKDC MVP FUBP3 | 8.43e-09 | 844 | 172 | 20 | 25963833 | |
| Pubmed | RPL28 MYH9 SRSF4 SRSF5 ACAT1 ELP1 UNC45A DRG1 GTF2F2 IGF2BP3 IGF2BP2 PNPLA6 EIF2S3 MRPS5 PRKDC MVP HDLBP | 9.22e-09 | 601 | 172 | 17 | 33658012 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | WHRN RANBP10 ANKS6 SRSF5 ANK3 NSF DYNC2H1 ALKBH2 PSMD7 OSGEP FAAP100 RSRC1 KIF7 DRG1 EXOC5 RAB28 PTPN13 KIF3B EML5 RDH11 SEC23IP DYNC1LI1 CAVIN1 IFT122 PRKG2 | 9.34e-09 | 1321 | 172 | 25 | 27173435 |
| Pubmed | DPYSL2 BTF3L4 MYH9 MIA3 ANK3 ACAT1 SPTBN1 GRIA1 PSMD7 RABGAP1 PALMD FAM171B PDHX KHSRP G3BP2 STRN4 MAP3K10 DYNC1LI1 MRPS5 EIF3C FKBP2 EPB41L2 HDLBP | 1.19e-08 | 1139 | 172 | 23 | 36417873 | |
| Pubmed | RPL28 SCN11A MYH9 PPAN ZNF174 MTRES1 SPTBN1 GRIA1 PSMD7 DNAJB3 PSMA8 KHSRP ABCB1 PHEX SPTBN4 GTF2IRD2B RDH11 FUBP1 SEC23IP STRN4 GTF2IRD2 IFT122 PRKDC ABCC2 FUBP3 ARHGAP21 | 1.22e-08 | 1442 | 172 | 26 | 35575683 | |
| Pubmed | MIA3 KHSRP DRG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 SEC23IP MYH16 SYMPK HDLBP | 1.46e-08 | 220 | 172 | 11 | 24550385 | |
| Pubmed | DPYSL2 MYH9 ABCB7 SRSF4 SRSF5 ZFYVE16 ACAT1 NSF PSMD7 UNC45A SUCLG2 PDHX HNRNPK MTA1 ABCB10 CIAPIN1 SEC23IP DYNC1LI1 PRKDC EPB41L2 | 1.62e-08 | 878 | 172 | 20 | 37223481 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | RPL28 MYH9 EPPK1 SRSF4 SPTBN1 HNRNPK KHSRP IGF2BP1 IGF2BP3 IGF2BP2 FUBP1 EIF3C PRKDC FUBP3 HDLBP | 1.79e-08 | 477 | 172 | 15 | 31300519 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPL28 DPYSL2 EDF1 MYH9 EPPK1 NSF SPTBN1 RABGAP1 SUCLG2 TSFM KHSRP DRG1 ARG1 IGF2BP2 RDH11 PIK3C2A G3BP2 CIAPIN1 CAVIN1 EIF3C PRKDC MVP FUBP3 SYMPK HDLBP | 1.83e-08 | 1367 | 172 | 25 | 32687490 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | RPL28 MYH9 SRSF5 ACAT1 SPTBN1 UNC45A HNRNPK DRG1 ARG1 FARSA IGF2BP2 EIF2S3 G3BP2 EIF3C PRKDC MVP | 2.13e-08 | 558 | 172 | 16 | 27591049 |
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 3.02e-08 | 97 | 172 | 8 | 37151849 | |
| Pubmed | RPL28 MYH9 PPAN SRSF4 SRSF5 SUCLG2 HNRNPK DRG1 IGF2BP1 IGF2BP3 EIF2S3 G3BP2 MRPS5 PRKDC | 3.07e-08 | 425 | 172 | 14 | 21081503 | |
| Pubmed | 3.18e-08 | 138 | 172 | 9 | 30320910 | ||
| Pubmed | MYH9 EPPK1 NSF DYNC2H1 NUP210L SPTBN1 ABCB6 UNC45A KHSRP IGF2BP3 CSF3 RDH11 FUBP1 EIF2S3 G3BP2 ARHGAP21 CA3 HDLBP | 4.40e-08 | 754 | 172 | 18 | 35906200 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RPL28 DPYSL2 BTF3L4 EDF1 MIA3 ABCB7 STXBP4 PKP4 UNC45A OSGEP ARHGEF11 DNAH7 PDHX TSFM KIF7 MRPL14 CIAPIN1 DYNC1LI1 ARHGAP21 | 5.39e-08 | 853 | 172 | 19 | 28718761 |
| Pubmed | RPL28 DPYSL2 MYH9 SPTBN1 HNRNPK KHSRP IGF2BP3 FUBP1 EIF2S3 G3BP2 EIF3C PRKDC HDLBP | 1.04e-07 | 397 | 172 | 13 | 21319273 | |
| Pubmed | DPYSL2 EPPK1 ACAT1 SPTBN1 HNRNPK KHSRP DRG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 EIF2S3 G3BP2 EIF3C PRKDC FUBP3 HDLBP | 1.04e-07 | 711 | 172 | 17 | 33022573 | |
| Pubmed | BTF3L4 EDF1 PPAN NSF PKP4 ABCB6 UNC45A ARHGEF11 RSRC1 DRG1 RSBN1 FARSA GTF2F2 PTPN13 MTA1 PNPLA6 PIK3C2A EIF2S3 STRN4 MLH1 MRPS5 EIF3C SDCBP EPB41L2 HDLBP | 1.05e-07 | 1497 | 172 | 25 | 31527615 | |
| Pubmed | RPL28 MYH9 PPAN SRSF4 SRSF5 HNRNPK RSRC1 DRG1 IGF2BP1 IGF2BP3 IGF2BP2 EIF2S3 G3BP2 MRPS5 FUBP3 SYMPK HDLBP | 1.08e-07 | 713 | 172 | 17 | 29802200 | |
| Pubmed | β-Actin mRNA interactome mapping by proximity biotinylation. | 1.10e-07 | 24 | 172 | 5 | 31189591 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RPL28 SRSF4 ACAT1 NSF DNAJB3 PSMA8 HNRNPK KHSRP FARSA IGF2BP1 IGF2BP3 IGF2BP2 FUBP1 G3BP2 EIF3C PRKDC FUBP3 | 1.11e-07 | 714 | 172 | 17 | 28302793 |
| Pubmed | RANBP10 MYH9 SPTBN1 PDHX HNRNPK KHSRP IGF2BP1 IGF2BP3 IGF2BP2 FUBP1 EIF2S3 G3BP2 EIF3C PRKDC FUBP3 | 1.17e-07 | 551 | 172 | 15 | 34728620 | |
| Pubmed | Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. | 1.19e-07 | 3 | 172 | 3 | 17296566 | |
| Pubmed | Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. | 1.19e-07 | 3 | 172 | 3 | 29476152 | |
| Pubmed | Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock. | 1.19e-07 | 3 | 172 | 3 | 32668274 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 20627640 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 8940189 | ||
| Pubmed | Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. | 1.19e-07 | 3 | 172 | 3 | 16049158 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 9891060 | ||
| Pubmed | VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. | 1.19e-07 | 3 | 172 | 3 | 15601260 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 20080952 | ||
| Pubmed | MYH9 SRSF4 SPTBN1 PSMD7 FARSA IGF2BP1 IGF2BP3 G3BP2 EIF3C PRKDC EPB41L2 HDLBP | 1.21e-07 | 334 | 172 | 12 | 30425250 | |
| Pubmed | DPYSL2 MYH9 MIA3 ABCB7 EPPK1 ZFYVE16 ACAT1 UNC45A OSGEP LARS2 TSFM DRG1 IGF2BP3 PIK3C3 FUBP1 EIF2S3 MAPKAPK3 MLH1 CAVIN1 PRKDC NUP188 SDCBP EPB41L2 | 1.25e-07 | 1297 | 172 | 23 | 33545068 | |
| Pubmed | NSF SPTBN1 ELP1 PSMD7 UNC45A HNRNPK IGF2BP1 EIF2S3 SEC23IP DYNC1LI1 EIF3C PRKDC NUP188 FUBP3 EPB41L2 SYMPK | 1.33e-07 | 638 | 172 | 16 | 33239621 | |
| Pubmed | RPL28 MYH9 SRSF5 ACAT1 SPTBN1 HNRNPK DRG1 ARG1 IGF2BP1 IGF2BP3 IGF2BP2 RDH11 EIF2S3 EIF3C PRKDC FUBP3 | 1.42e-07 | 641 | 172 | 16 | 36057605 | |
| Pubmed | RPL28 MYH9 SPTBN1 OSGEP PDHX HNRNPK DRG1 GTF2F2 IGF2BP3 RDH11 EIF2S3 CAVIN1 PRKDC HDLBP | 1.67e-07 | 488 | 172 | 14 | 31324722 | |
| Pubmed | DPYSL2 BTF3L4 EDF1 MYH9 ACAT1 CHD9 RABGAP1 UNC45A KHSRP FARSA GTF2F2 POLR3D MTA1 FUBP1 CIAPIN1 CAVIN1 PRKDC FUBP3 FKBP5 SYMPK | 1.67e-07 | 1014 | 172 | 20 | 32416067 | |
| Pubmed | 1.70e-07 | 121 | 172 | 8 | 34029587 | ||
| Pubmed | MYH9 PPAN SRSF4 SRSF5 NSF ELP1 PSMD7 HNRNPK KHSRP DRG1 RSBN1 RDH11 G3BP2 EIF3C PRKDC FUBP3 | 1.82e-07 | 653 | 172 | 16 | 33742100 | |
| Pubmed | 1.86e-07 | 11 | 172 | 4 | 36411454 | ||
| Pubmed | 2.22e-07 | 173 | 172 | 9 | 23979707 | ||
| Pubmed | 2.33e-07 | 174 | 172 | 9 | 35031058 | ||
| Pubmed | RPL28 MYH9 PPAN SRSF4 SRSF5 UNC45A RSRC1 IGF2BP3 IGF2BP2 PNPLA6 G3BP2 MRPS5 CAVIN1 EIF3C PRKDC MVP FUBP3 SYMPK | 2.46e-07 | 847 | 172 | 18 | 35850772 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | SPTBN1 PSMA8 RYR3 DRG1 G3BP2 EIF3C PRKDC NUP188 CCDC157 HDLBP | 2.57e-07 | 231 | 172 | 10 | 36597993 |
| Pubmed | RPL28 MYH9 PPAN SRSF4 SRSF5 NSF PKP4 SPTBN1 CHD9 UNC45A HNRNPK FARSA IGF2BP3 IGF2BP2 PIK3C2A EIF2S3 G3BP2 MLH1 PRKDC MVP FKBP5 HDLBP | 2.62e-07 | 1247 | 172 | 22 | 27684187 | |
| Pubmed | RPL28 MYH9 SPTBN1 HNRNPK KHSRP IGF2BP1 FUBP1 EIF2S3 G3BP2 PRKDC FUBP3 | 2.86e-07 | 295 | 172 | 11 | 26209609 | |
| Pubmed | MIA3 ANK3 ZFYVE16 ZNF174 STXBP4 PKP4 SPTBN1 ELP1 DAPK3 PSMD7 FAM171B KIF7 IGF2BP2 PTPN13 MLH1 EIF3C FKBP5 CBX2 SYMPK HDLBP | 2.86e-07 | 1049 | 172 | 20 | 27880917 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL28 MYH9 PPAN EPPK1 PKP4 SPTBN1 DAPK3 UNC45A HNRNPK DRG1 ARG1 FARSA GTF2F2 IGF2BP2 PNPLA6 EIF2S3 G3BP2 CAVIN1 PRKDC MVP EPB41L2 HDLBP | 3.00e-07 | 1257 | 172 | 22 | 36526897 |
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 3.95e-07 | 135 | 172 | 8 | 29859926 | |
| Pubmed | RPL28 MYH9 EPPK1 SRSF5 SPTBN1 UNC45A HNRNPK ARG1 G3BP2 PRKDC | 4.42e-07 | 245 | 172 | 10 | 21182205 | |
| Pubmed | RPL28 DPYSL2 EDF1 PPAN SRSF5 HNRNPK KHSRP IGF2BP1 GTF2F2 IGF2BP2 G3BP2 EIF3C PRKDC MVP HDLBP | 4.73e-07 | 615 | 172 | 15 | 31048545 | |
| Pubmed | H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. | 4.74e-07 | 4 | 172 | 3 | 10875929 | |
| Pubmed | mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. | 4.74e-07 | 4 | 172 | 3 | 21576258 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 15225648 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 26160756 | ||
| Pubmed | IMP2 axonal localization, RNA interactome, and function in the development of axon trajectories. | 4.74e-07 | 4 | 172 | 3 | 27385015 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 27184842 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 11937269 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 22655043 | ||
| Pubmed | 4.86e-07 | 59 | 172 | 6 | 32382008 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 4.86e-07 | 59 | 172 | 6 | 16083285 | |
| Pubmed | EPPK1 PSMD7 RABGAP1 UNC45A SUCLG2 ABCB10 G3BP2 DYNC1LI1 FLCN IFT122 EIF3C PRKDC SDCBP | 5.16e-07 | 457 | 172 | 13 | 22190034 | |
| Pubmed | RPL28 MYH9 ACAT1 SPTBN1 HNRNPK KHSRP DRG1 IGF2BP1 IGF2BP3 IGF2BP2 FUBP1 EIF2S3 PRKDC NUP188 FUBP3 SDCBP | 5.22e-07 | 707 | 172 | 16 | 19738201 | |
| Interaction | SERBP1 interactions | RPL28 DPYSL2 MYH9 ABCB7 SRSF4 SRSF5 ZFYVE16 ACAT1 NSF PSMD7 UNC45A SUCLG2 PDHX TSFM HNRNPK DRG1 IGF2BP1 GTF2F2 IGF2BP2 MTA1 ABCB10 RDH11 FUBP1 EIF2S3 G3BP2 CIAPIN1 DHODH SEC23IP DYNC1LI1 PRKDC FUBP3 EPB41L2 SYMPK HDLBP GULP1 | 7.79e-09 | 1432 | 169 | 35 | int:SERBP1 |
| Interaction | LGALS9 interactions | RPL28 MYH9 ABCB7 ACAT1 NSF SPTBN1 HNRNPK KHSRP ABCB1 FARSA IGF2BP1 IGF2BP3 EIF2S3 SEC23IP EIF3C NUP188 ABCC2 FUBP3 SDCBP EPB41L2 | 1.17e-07 | 588 | 169 | 20 | int:LGALS9 |
| Interaction | BAP1 interactions | RPL28 DPYSL2 MYH9 EPPK1 SRSF4 SRSF5 ANK3 NSF SPTBN1 PSMD7 UNC45A DNAJB3 MAP3K1 HNRNPK KHSRP DRG1 IGF2BP1 IGF2BP3 IGF2BP2 MTA1 FUBP1 EIF2S3 G3BP2 DHODH DYNC1LI1 MRPS5 PRKDC FKBP5 EPB41L2 SYMPK HDLBP | 1.44e-07 | 1314 | 169 | 31 | int:BAP1 |
| Interaction | NAA40 interactions | RPL28 DPYSL2 BTF3L4 EDF1 MYH9 ZFYVE16 STXBP4 PSMD7 UNC45A HNRNPK KHSRP IGF2BP1 GTF2F2 IGF2BP3 IGF2BP2 PTPN13 EIF2S3 CIAPIN1 SEC23IP MLH1 EIF3C PRKDC ARHGAP21 SDCBP EPB41L2 HDLBP | 1.77e-07 | 978 | 169 | 26 | int:NAA40 |
| Interaction | C8orf82 interactions | ACAT1 MTRES1 LARS2 TSFM HNRNPK IGF2BP1 IGF2BP3 IGF2BP2 FUBP1 MRPS5 FUBP3 | 1.80e-07 | 168 | 169 | 11 | int:C8orf82 |
| Interaction | CYLD interactions | RPL28 DPYSL2 MYH9 SRSF5 ACAT1 NSF SPTBN1 RUSC1 GRIA1 UNC45A HNRNPK KHSRP DRG1 ARG1 FARSA IGF2BP2 PNPLA6 PIK3C3 EIF2S3 G3BP2 CIAPIN1 EIF3C PRKDC MVP | 2.74e-07 | 868 | 169 | 24 | int:CYLD |
| Interaction | GLDC interactions | MYH9 SRSF4 ACAT1 PKP4 SPTBN1 HNRNPK KHSRP IGF2BP1 IGF2BP3 FUBP1 EIF2S3 G3BP2 FUBP3 ARHGAP21 | 5.68e-07 | 321 | 169 | 14 | int:GLDC |
| Interaction | FMR1 interactions | RPL28 DPYSL2 MIA3 NSF PKP4 SPTBN1 DAPK3 KHSRP DRG1 IGF2BP1 IGF2BP3 IGF2BP2 FUBP1 G3BP2 MVP FUBP3 ARHGAP21 HDLBP | 6.29e-07 | 536 | 169 | 18 | int:FMR1 |
| Interaction | RHOA interactions | DPYSL2 MIA3 ABCB7 EPPK1 ANK3 NSF PKP4 SPTBN1 DCBLD1 OSGEP FAM171B ARHGEF11 ARHGEF25 PDHX MAP3K1 TSFM PTPN13 PNPLA6 RDH11 PIK3C2A PIK3C3 SEC23IP MRPS5 CAVIN1 PRKDC FUBP3 ARHGAP21 SDCBP | 7.81e-07 | 1199 | 169 | 28 | int:RHOA |
| Interaction | ATG16L1 interactions | EDF1 PPAN SRSF5 ANK3 ACAT1 STXBP4 KIF16B ELP1 CCDC168 RABGAP1 FAM171B PDHX RSRC1 KIF7 DRG1 EXOC5 FARSA GTF2F2 PTPN13 MRPL14 PIK3C2A PIK3C3 G3BP2 STRN4 CAVIN1 EIF3C HDLBP | 1.37e-06 | 1161 | 169 | 27 | int:ATG16L1 |
| Interaction | FLOT1 interactions | MYH9 ANK3 ACAT1 STXBP4 PKP4 SPTBN1 FAM171B ARHGEF25 ARG1 IGF2BP1 PTPN13 SURF1 MRPS5 NUP188 ARHGAP21 EPB41L2 | 2.63e-06 | 475 | 169 | 16 | int:FLOT1 |
| Interaction | BMI1 interactions | WHRN SRSF4 SPTBN1 ABCB6 RYR3 RSRC1 KHSRP ARG1 IGF2BP1 IGF2BP3 IGF2BP2 G3BP2 MAPKAPK3 SEC23IP CAVIN1 EIF3C PRKDC FUBP3 CBX2 | 2.91e-06 | 659 | 169 | 19 | int:BMI1 |
| Interaction | MRPL32 interactions | 3.58e-06 | 144 | 169 | 9 | int:MRPL32 | |
| Interaction | MEX3A interactions | MYH9 EPPK1 ABL1 SRSF4 SPTBN1 LARS2 PSMA8 IGF2BP1 IGF2BP2 ABCB10 MRPL14 PRKDC DNAH5 FUBP3 | 4.64e-06 | 384 | 169 | 14 | int:MEX3A |
| Interaction | FBXO32 interactions | SRSF4 NSF ELP1 UNC45A HNRNPK FARSA IGF2BP1 MLH1 DYNC1LI1 MRPS5 CAVIN1 FUBP3 CA3 MYBPC3 | 4.93e-06 | 386 | 169 | 14 | int:FBXO32 |
| Interaction | FAM120C interactions | MIA3 KIF7 IGF2BP1 IGF2BP2 PIK3C2A G3BP2 NUP188 FUBP3 PHIP HDLBP | 5.01e-06 | 191 | 169 | 10 | int:FAM120C |
| Interaction | CFTR interactions | RPL28 EDF1 MYH9 ABCB7 EPPK1 MTRES1 SPTBN1 PSMD7 UNC45A OSGEP SUCLG2 FAAP100 PSMA8 PDHX HNRNPK RYR3 KHSRP DRG1 FARSA GTF2F2 IGF2BP3 IGF2BP2 GSDME ABCB10 RDH11 EIF2S3 CAVIN1 PRKDC MVP HDLBP | 5.43e-06 | 1480 | 169 | 30 | int:CFTR |
| Interaction | RICTOR interactions | RPL28 DPYSL2 MYH9 NSF SPTBN1 UNC45A HNRNPK KHSRP ARG1 IGF2BP1 IGF2BP2 KIF3B RDH11 SEC23IP STRN4 PRKDC MVP PHIP EPB41L2 HDLBP | 6.05e-06 | 759 | 169 | 20 | int:RICTOR |
| Interaction | BIRC3 interactions | RPL28 MYH9 SRSF5 ACAT1 NSF DYNC2H1 SPTBN1 PSMD7 TSFM HNRNPK KHSRP DRG1 FARSA IGF2BP1 RDH11 FUBP1 EIF2S3 G3BP2 SEC23IP DYNC1LI1 PRKDC NUP188 DNAH5 FUBP3 PHIP SDCBP EPB41L2 HDLBP | 6.13e-06 | 1334 | 169 | 28 | int:BIRC3 |
| Interaction | RPA4 interactions | RPL28 DPYSL2 SPTBN1 UNC45A HNRNPK KHSRP DRG1 IGF2BP1 IGF2BP3 IGF2BP2 STRN4 EIF3C FUBP3 EPB41L2 HDLBP | 6.55e-06 | 452 | 169 | 15 | int:RPA4 |
| Interaction | RHOB interactions | ABCB7 EPPK1 ANK3 ZFYVE16 ACAT1 NSF PKP4 SPTBN1 KIF16B DCBLD1 FAM171B ARHGEF11 PDHX FARSA PTPN13 RDH11 MRPS5 CAVIN1 ARHGAP21 SDCBP EPB41L2 | 7.81e-06 | 840 | 169 | 21 | int:RHOB |
| Interaction | CLEC14A interactions | 7.93e-06 | 86 | 169 | 7 | int:CLEC14A | |
| Interaction | NFX1 interactions | RANBP10 RPL28 MYH9 PPAN SRSF4 PSMD7 KHSRP DRG1 ARG1 IGF2BP1 IGF2BP3 MRPL14 EIF2S3 PRKDC HDLBP | 9.42e-06 | 466 | 169 | 15 | int:NFX1 |
| Interaction | MCM2 interactions | RPL28 DPYSL2 MYH9 EPPK1 ANK3 PKP4 ELP1 PSMA8 MAP3K1 HNRNPK KHSRP ARG1 FARSA IGF2BP2 MTA1 FUBP1 PHACTR3 PYGM EIF3C PRKDC MVP FUBP3 FKBP5 CBX2 | 1.23e-05 | 1081 | 169 | 24 | int:MCM2 |
| Interaction | MRPS31 interactions | DPYSL2 PPAN SRSF5 MTRES1 TSFM IGF2BP1 IGF2BP3 IGF2BP2 SURF1 MRPS5 PYGM FUBP3 | 1.25e-05 | 310 | 169 | 12 | int:MRPS31 |
| Interaction | AXL interactions | MIA3 PPAN EPPK1 HNRNPK IGF2BP3 G3BP2 MAP3K10 DYNC1LI1 MRPS5 PRKDC NUP188 RELT EPB41L2 | 1.48e-05 | 369 | 169 | 13 | int:AXL |
| Interaction | ZC3H18 interactions | RPL28 MYH9 PPAN SRSF4 SRSF5 SPTBN1 HNRNPK RSRC1 KHSRP ARG1 RSBN1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 MRPL14 EIF2S3 MRPS5 EIF3C FUBP3 EPB41L2 | 1.49e-05 | 877 | 169 | 21 | int:ZC3H18 |
| Interaction | CEBPA interactions | BTF3L4 EDF1 MYH9 SRSF5 ZNF174 SPTBN1 CHD9 PSMD7 HNRNPK KHSRP DRG1 IGF2BP1 GTF2F2 IGF2BP3 IGF2BP2 MTA1 FUBP1 EIF2S3 G3BP2 CIAPIN1 DYNC1LI1 PRKDC FUBP3 FKBP5 SDCBP HDLBP | 1.50e-05 | 1245 | 169 | 26 | int:CEBPA |
| Interaction | CDC42 interactions | RPL28 DPYSL2 EDF1 ABCB7 ANK3 NSF DYNC2H1 PKP4 SPTBN1 DCBLD1 ARHGEF11 ARHGEF25 TSFM ARG1 FARSA IGF2BP1 PTPN13 PIK3C2A SEC23IP MAP3K10 DYNC1LI1 MRPS5 CAVIN1 PRKDC ARHGAP21 SDCBP HDLBP | 1.52e-05 | 1323 | 169 | 27 | int:CDC42 |
| Interaction | NR2C2 interactions | RPL28 MYH9 PPAN SRSF4 ACAT1 NSF PSMD7 SUCLG2 PSMA8 TSFM HNRNPK RSRC1 KHSRP DRG1 RSBN1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 MTA1 ABCB10 FUBP1 EIF2S3 MRPS5 PRKDC FUBP3 PHIP FKBP5 | 1.56e-05 | 1403 | 169 | 28 | int:NR2C2 |
| Interaction | CMTR1 interactions | RPL28 SRSF4 SRSF5 SPTBN1 KIF16B HNRNPK IGF2BP3 IGF2BP2 G3BP2 MVP | 1.60e-05 | 218 | 169 | 10 | int:CMTR1 |
| Interaction | SIRT7 interactions | DPYSL2 MYH9 EPPK1 SRSF4 SRSF5 ACAT1 SPTBN1 ELP1 KHSRP IGF2BP3 IGF2BP2 PRKDC NUP188 MVP FUBP3 PHIP EPB41L2 SYMPK HDLBP | 1.63e-05 | 744 | 169 | 19 | int:SIRT7 |
| Interaction | SNW1 interactions | MYH9 EPPK1 SRSF5 NSF SPTBN1 RABGAP1 UNC45A HNRNPK DRG1 EXOC5 GSDME FUBP1 G3BP2 MLH1 PRKDC MVP SYMPK HDLBP GULP1 | 1.72e-05 | 747 | 169 | 19 | int:SNW1 |
| Interaction | PRC1 interactions | BDP1 MYH9 PPAN EPPK1 SRSF5 SPTBN1 PSMD7 UNC45A HNRNPK KHSRP NRP2 SPTBN4 IGF2BP1 IGF2BP3 IGF2BP2 KIF3B G3BP2 CAVIN1 PRKDC NUP188 PHIP EPB41L2 | 2.23e-05 | 973 | 169 | 22 | int:PRC1 |
| Interaction | TENT5C interactions | 2.30e-05 | 139 | 169 | 8 | int:TENT5C | |
| Interaction | PRKY interactions | 2.42e-05 | 140 | 169 | 8 | int:PRKY | |
| Interaction | MIRLET7A3 interactions | 2.44e-05 | 102 | 169 | 7 | int:MIRLET7A3 | |
| Interaction | EFTUD2 interactions | RPL28 BTF3L4 EDF1 MYH9 SRSF5 SPTBN1 PHLDA3 ELP1 UNC45A HNRNPK KHSRP DRG1 FARSA IGF2BP1 GTF2F2 IGF2BP3 MRPL14 EIF2S3 G3BP2 MRPS5 CAVIN1 EIF3C PRKDC FKBP5 SDCBP EPB41L2 SYMPK HDLBP | 2.80e-05 | 1449 | 169 | 28 | int:EFTUD2 |
| Interaction | GRSF1 interactions | RPL28 SRSF4 ACAT1 MTRES1 LARS2 TSFM IGF2BP1 IGF2BP3 IGF2BP2 MRPL14 SURF1 G3BP2 MRPS5 FUBP3 HDLBP | 3.03e-05 | 515 | 169 | 15 | int:GRSF1 |
| Interaction | CDC5L interactions | MYH9 EPPK1 SRSF4 SRSF5 NSF SPTBN1 ELP1 UNC45A HNRNPK DRG1 EXOC5 GSDME KANSL1 FUBP1 DYNC1LI1 PRKDC MVP SYMPK HDLBP GULP1 | 3.37e-05 | 855 | 169 | 20 | int:CDC5L |
| Interaction | MIR18A interactions | 3.40e-05 | 73 | 169 | 6 | int:MIR18A | |
| Interaction | MIRLET7A1 interactions | 3.53e-05 | 108 | 169 | 7 | int:MIRLET7A1 | |
| Interaction | KCTD13 interactions | RPL28 DPYSL2 MYH9 SRSF5 ANK3 ACAT1 NSF PKP4 SPTBN1 ELP1 GRIA1 DAPK3 ARHGEF11 PDHX HNRNPK KHSRP SPTBN4 FARSA NWD2 PNPLA6 EIF2S3 G3BP2 STRN4 ARHGAP21 SDCBP EPB41L2 HDLBP | 3.81e-05 | 1394 | 169 | 27 | int:KCTD13 |
| Interaction | CCDC8 interactions | RPL28 EPPK1 NSF ELP1 KHSRP KIF7 DRG1 ARG1 IGF2BP1 IGF2BP3 IGF2BP2 ARID5B EIF3C PRKDC NUP188 EPB41L2 HDLBP | 3.88e-05 | 656 | 169 | 17 | int:CCDC8 |
| Interaction | GSK3B interactions | DPYSL2 MYH9 MIA3 ARHGEF11 MAP3K1 HNRNPK KHSRP ARG1 SPTBN4 IGF2BP1 GTF2F2 IGF2BP3 PTPN13 FUBP1 CAVIN1 EIF3C PRKDC MVP ARHGAP21 FKBP5 | 4.17e-05 | 868 | 169 | 20 | int:GSK3B |
| Interaction | RBM8A interactions | RPL28 EDF1 SPTBN1 HNRNPK DRG1 RSBN1 IGF2BP1 IGF2BP3 FUBP1 EIF2S3 G3BP2 CIAPIN1 EIF3C HDLBP | 4.73e-05 | 473 | 169 | 14 | int:RBM8A |
| Interaction | RECQL4 interactions | RANBP10 RPL28 SRSF4 ZFYVE16 ACAT1 WASHC1 ELP1 PSMD7 PSMA8 HNRNPK KHSRP DRG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 POLR3D MTA1 MRPL14 G3BP2 MRPS5 EIF3C PRKDC NUP188 FUBP3 FKBP5 HDLBP | 4.75e-05 | 1412 | 169 | 27 | int:RECQL4 |
| Interaction | MIR92A1 interactions | 4.96e-05 | 78 | 169 | 6 | int:MIR92A1 | |
| Interaction | MEN1 interactions | RPL28 MYH9 PPAN SRSF4 SRSF5 UNC45A KHSRP DRG1 RSBN1 GTF2F2 IGF2BP3 IGF2BP2 PNPLA6 KANSL1 FUBP1 G3BP2 CAVIN1 EIF3C NUP188 MVP FUBP3 SYMPK | 5.17e-05 | 1029 | 169 | 22 | int:MEN1 |
| Interaction | ACE2 interactions | RPL28 MYH9 SRSF5 ZFYVE16 ACAT1 SPTBN1 PSMD7 RABGAP1 HNRNPK KHSRP DRG1 ARG1 IGF2BP1 IGF2BP3 IGF2BP2 RDH11 EIF2S3 G3BP2 CAVIN1 EIF3C PRKDC MVP FUBP3 | 5.26e-05 | 1106 | 169 | 23 | int:ACE2 |
| Interaction | PARP12 interactions | 5.53e-05 | 49 | 169 | 5 | int:PARP12 | |
| Interaction | MRPS18B interactions | MYH9 SRSF5 MTRES1 TSFM IGF2BP1 IGF2BP3 IGF2BP2 SURF1 MRPS5 CBX2 HDLBP | 5.87e-05 | 307 | 169 | 11 | int:MRPS18B |
| Interaction | MRPS35 interactions | PPAN SRSF4 SRSF5 MTRES1 TSFM IGF2BP3 IGF2BP2 SURF1 MRPS5 EIF3C ABCC2 | 5.87e-05 | 307 | 169 | 11 | int:MRPS35 |
| Interaction | PINK1 interactions | RPL28 MYH9 EPPK1 SRSF4 NLRX1 SPTBN1 HNRNPK KHSRP IGF2BP1 IGF2BP3 IGF2BP2 FUBP1 EIF3C PRKDC FUBP3 FKBP5 HDLBP | 5.94e-05 | 679 | 169 | 17 | int:PINK1 |
| Interaction | SMS interactions | 6.22e-05 | 118 | 169 | 7 | int:SMS | |
| Interaction | NUDCD2 interactions | DPYSL2 MYH9 EPPK1 SPTBN1 HNRNPK FBXO24 G3BP2 SEC23IP EIF3C PRKDC MVP FKBP5 SYMPK | 6.22e-05 | 424 | 169 | 13 | int:NUDCD2 |
| Interaction | PHB1 interactions | RPL28 MYH9 ABCB7 SRSF5 NSF MTRES1 TSFM HNRNPK KHSRP DRG1 RSBN1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 ABCB10 EIF2S3 SURF1 G3BP2 MAP3K10 DYNC1LI1 PRKDC NUP188 | 6.63e-05 | 1123 | 169 | 23 | int:PHB1 |
| Interaction | USP14 interactions | MYH9 SRSF4 SPTBN1 PSMD7 UNC45A HNRNPK FARSA IGF2BP1 IGF2BP3 G3BP2 EIF3C PRKDC EPB41L2 HDLBP | 6.75e-05 | 489 | 169 | 14 | int:USP14 |
| Interaction | CEBPB interactions | RPL28 DPYSL2 EDF1 MYH9 SRSF4 SRSF5 ACAT1 NSF ELP1 HNRNPK KHSRP DRG1 ARG1 FARSA IGF2BP1 IGF2BP2 MTA1 FUBP1 EIF2S3 G3BP2 SEC23IP DYNC1LI1 EIF3C PRKDC FUBP3 SDCBP SYMPK | 6.88e-05 | 1443 | 169 | 27 | int:CEBPB |
| Interaction | MIR7-2 interactions | 7.53e-05 | 84 | 169 | 6 | int:MIR7-2 | |
| Interaction | LGR4 interactions | MYH9 PDHX HNRNPK KHSRP ABCB10 RDH11 PIK3C2A PRKDC CCDC157 HDLBP | 7.59e-05 | 262 | 169 | 10 | int:LGR4 |
| Interaction | PPP1CA interactions | DPYSL2 MYH9 SFRP2 SRSF5 ZFYVE16 RABGAP1 PDHX HNRNPK IGF2BP1 MRPL14 SH3RF2 FUBP1 PHACTR3 SEC23IP PYGM CAVIN1 PRKDC | 8.04e-05 | 696 | 169 | 17 | int:PPP1CA |
| Interaction | MIR107 interactions | 8.05e-05 | 85 | 169 | 6 | int:MIR107 | |
| Interaction | MIR17 interactions | 8.05e-05 | 85 | 169 | 6 | int:MIR17 | |
| Interaction | MIR93 interactions | 8.05e-05 | 85 | 169 | 6 | int:MIR93 | |
| Interaction | MIR16-2 interactions | 8.05e-05 | 85 | 169 | 6 | int:MIR16-2 | |
| Interaction | DUX4 interactions | MYH9 SRSF5 SPTBN1 HNRNPK IGF2BP1 IGF2BP3 EIF2S3 CAVIN1 PRKDC | 8.36e-05 | 214 | 169 | 9 | int:DUX4 |
| Interaction | MIR20B interactions | 8.59e-05 | 86 | 169 | 6 | int:MIR20B | |
| Interaction | AKAP1 interactions | MIA3 ABCB7 EPPK1 KIF16B UNC45A DRG1 FARSA IGF2BP3 IGF2BP2 PIK3C2A EIF2S3 EIF3C NUP188 FUBP3 | 9.11e-05 | 503 | 169 | 14 | int:AKAP1 |
| Interaction | RAB5A interactions | RANBP10 RPL28 MIA3 ZFYVE16 KIF16B FARSA IGF2BP2 KIF3B RDH11 PIK3C3 SEC23IP CAVIN1 EIF3C PRKDC MVP SDCBP HDLBP | 9.56e-05 | 706 | 169 | 17 | int:RAB5A |
| Interaction | MIR138-2 interactions | 9.77e-05 | 88 | 169 | 6 | int:MIR138-2 | |
| Interaction | PTEN interactions | RPL28 ACAT1 SPTBN1 ELP1 PSMD7 SUCLG2 RYR3 KHSRP DRG1 EXOC5 FARSA IGF2BP1 PTPN13 FUBP1 G3BP2 PRKDC MVP FUBP3 FKBP5 SDCBP | 1.06e-04 | 929 | 169 | 20 | int:PTEN |
| Interaction | DRG1 interactions | RPL28 PPAN ABL1 DRG1 RSBN1 IGF2BP1 IGF2BP3 EIF2S3 G3BP2 EIF3C FKBP5 HDLBP | 1.10e-04 | 388 | 169 | 12 | int:DRG1 |
| Interaction | MEX3B interactions | 1.11e-04 | 222 | 169 | 9 | int:MEX3B | |
| Interaction | MIR200C interactions | 1.18e-04 | 91 | 169 | 6 | int:MIR200C | |
| Interaction | MIR155 interactions | 1.25e-04 | 92 | 169 | 6 | int:MIR155 | |
| Interaction | MIR214 interactions | 1.33e-04 | 93 | 169 | 6 | int:MIR214 | |
| Interaction | KCNA3 interactions | RPL28 MYH9 EPPK1 ANK3 ZFYVE16 NSF SPTBN1 CHD9 UNC45A HNRNPK FARSA PTPN13 EIF2S3 SEC23IP PRKDC DNAH5 ARHGAP21 EPB41L2 HDLBP | 1.34e-04 | 871 | 169 | 19 | int:KCNA3 |
| Interaction | SOX2 interactions | RANBP10 PPAN SRSF4 ACAT1 NSF PKP4 SPTBN1 CHD9 PSMD7 DNAJB3 PSMA8 HNRNPK KHSRP FARSA IGF2BP1 IGF2BP2 MTA1 FUBP1 G3BP2 ARID5B MRPS5 ABCC2 FUBP3 ARHGAP21 SDCBP CBX2 | 1.38e-04 | 1422 | 169 | 26 | int:SOX2 |
| Interaction | CUL1 interactions | RPL28 MYH9 PPAN SRSF4 SRSF5 ACAT1 SPTBN1 CCDC168 HNRNPK RYR3 KHSRP FARSA IGF2BP1 FBXO24 THRA G3BP2 PRKDC HDLBP MYBPC3 | 1.44e-04 | 876 | 169 | 19 | int:CUL1 |
| Interaction | TUT4 interactions | 1.49e-04 | 95 | 169 | 6 | int:TUT4 | |
| Interaction | UFL1 interactions | RANBP10 RPL28 MYH9 ANKS6 SRSF5 ACAT1 SPTBN1 PSMD7 DNAJB3 HNRNPK KHSRP DRG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 EIF2S3 G3BP2 MRPS5 PRKDC SDCBP | 1.52e-04 | 1031 | 169 | 21 | int:UFL1 |
| Interaction | LARP1 interactions | PPAN SRSF4 SRSF5 SPTBN1 PSMD7 RABGAP1 DRG1 FUBP1 EIF2S3 G3BP2 DYNC1LI1 EIF3C HDLBP | 1.56e-04 | 465 | 169 | 13 | int:LARP1 |
| Interaction | MIRLET7A2 interactions | 1.58e-04 | 96 | 169 | 6 | int:MIRLET7A2 | |
| Interaction | LARP7 interactions | RPL28 MYH9 PPAN SRSF4 SRSF5 NSF CHD9 PSMD7 PSMA8 HNRNPK DRG1 ARG1 RSBN1 IGF2BP1 IGF2BP3 IGF2BP2 MRPL14 MRPS5 EIF3C PRKDC FKBP5 HDLBP | 1.61e-04 | 1113 | 169 | 22 | int:LARP7 |
| Interaction | MIR21 interactions | 1.67e-04 | 97 | 169 | 6 | int:MIR21 | |
| Interaction | MIR363 interactions | 1.67e-04 | 97 | 169 | 6 | int:MIR363 | |
| Interaction | TRUB2 interactions | ABCB7 ACAT1 MTRES1 LARS2 PDHX TSFM HNRNPK IGF2BP3 IGF2BP2 MRPL14 MRPS5 | 1.86e-04 | 350 | 169 | 11 | int:TRUB2 |
| Interaction | MIR128-2 interactions | 1.87e-04 | 99 | 169 | 6 | int:MIR128-2 | |
| Interaction | METTL17 interactions | MYH9 ABCB7 ACAT1 LARS2 PDHX TSFM HNRNPK IGF2BP1 IGF2BP2 MRPL14 G3BP2 MRPS5 | 1.89e-04 | 411 | 169 | 12 | int:METTL17 |
| Interaction | MECP2 interactions | DPYSL2 BTF3L4 EDF1 MYH9 SRSF4 SRSF5 SPTBN1 CHD9 HNRNPK KHSRP DRG1 ARG1 FARSA IGF2BP1 IGF2BP3 IGF2BP2 PTPN13 NWD2 DYNC1LI1 EIF3C PRKDC MVP EPB41L2 SYMPK | 1.92e-04 | 1287 | 169 | 24 | int:MECP2 |
| Interaction | ILF3 interactions | RPL28 ABL1 SRSF5 UNC45A PDHX HNRNPK RSRC1 RSBN1 IGF2BP1 IGF2BP3 IGF2BP2 EIF2S3 G3BP2 PHACTR3 DHODH MRPS5 CAVIN1 PRKDC HDLBP | 1.93e-04 | 896 | 169 | 19 | int:ILF3 |
| Interaction | CAPZB interactions | RPL28 MYH9 SPTBN1 WASHC1 DAPK3 UNC45A HNRNPK KHSRP DRG1 FARSA IGF2BP1 IGF2BP3 POLR3D PIK3C2A PIK3C3 EIF2S3 G3BP2 DYNC1LI1 EIF3C FUBP3 FKBP5 | 1.93e-04 | 1049 | 169 | 21 | int:CAPZB |
| Interaction | MIR19A interactions | 1.98e-04 | 100 | 169 | 6 | int:MIR19A | |
| Interaction | LARP4B interactions | 1.99e-04 | 240 | 169 | 9 | int:LARP4B | |
| Interaction | MIRLET7B interactions | 2.09e-04 | 101 | 169 | 6 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 2.09e-04 | 101 | 169 | 6 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 2.09e-04 | 101 | 169 | 6 | int:MIR25 | |
| Interaction | FBXW7 interactions | RPL28 MYH9 SRSF4 SRSF5 ACAT1 SPTBN1 ELP1 FBP2 UNC45A HNRNPK DRG1 GTF2F2 IGF2BP3 IGF2BP2 PNPLA6 EIF2S3 SPRYD3 MRPS5 PRKDC MVP FKBP5 HDLBP GULP1 | 2.13e-04 | 1215 | 169 | 23 | int:FBXW7 |
| Interaction | CHD3 interactions | RPL28 MYH9 SRSF5 SPTBN1 FBP2 HNRNPK ARG1 IGF2BP1 IGF2BP3 IGF2BP2 MTA1 FUBP1 EIF3C PRKDC EPB41L2 SYMPK HDLBP | 2.19e-04 | 757 | 169 | 17 | int:CHD3 |
| Cytoband | Xp22.2-p22.1 | 1.39e-04 | 5 | 172 | 2 | Xp22.2-p22.1 | |
| GeneFamily | ATP binding cassette subfamily B | 4.95e-07 | 11 | 115 | 4 | 806 | |
| GeneFamily | FKBP prolyl isomerases | 1.91e-04 | 18 | 115 | 3 | 910 | |
| GeneFamily | PDZ domain containing | 4.24e-04 | 152 | 115 | 6 | 1220 | |
| GeneFamily | EF-hand domain containing|Spectrins | 8.25e-04 | 7 | 115 | 2 | 1113 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 1.10e-03 | 8 | 115 | 2 | 831 | |
| GeneFamily | RNA binding motif containing | 2.42e-03 | 213 | 115 | 6 | 725 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 2.54e-03 | 12 | 115 | 2 | 737 | |
| GeneFamily | Dyneins, cytoplasmic | 2.99e-03 | 13 | 115 | 2 | 538 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.12e-03 | 46 | 115 | 3 | 622 | |
| GeneFamily | Myosin heavy chains | 3.99e-03 | 15 | 115 | 2 | 1098 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 4.54e-03 | 16 | 115 | 2 | 14 | |
| GeneFamily | Dyneins, axonemal | 5.12e-03 | 17 | 115 | 2 | 536 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | ANK3 RABGAP1 NRP2 RSBN1 IGF2BP1 KANSL1 PIK3C2A PHIP HDLBP GULP1 | 6.70e-06 | 209 | 168 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | PAPPA2 MYH9 SFRP2 GJD2 ANK3 GRIA1 RABGAP1 COL25A1 FAM171B RYR3 NRP2 CLIP4 RSBN1 IGF2BP1 KANSL1 PIK3C2A MAP3K10 PHIP HDLBP GULP1 | 7.76e-06 | 818 | 168 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_1000 | NSF KIF16B ABCB1 CLIP4 PHEX GSDME PNPLA6 G3BP2 PHACTR3 MVP BTG4 | 1.65e-05 | 283 | 168 | 11 | gudmap_developingGonad_P2_ovary_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | EDF1 DAPK3 PSMD7 GTF2F2 CIAPIN1 MRPS5 EIF3C PHIP FKBP5 EPB41L2 CBX2 SYMPK HDLBP | 3.89e-05 | 429 | 168 | 13 | gudmap_developingGonad_e14.5_ testes_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | MYH9 SFRP2 ANK3 RABGAP1 NRP2 RSBN1 IGF2BP1 KANSL1 PIK3C2A PHIP HDLBP GULP1 | 5.94e-05 | 385 | 168 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | DPYSL2 ANK3 RABGAP1 FAM171B RYR3 NRP2 ARG1 RSBN1 KANSL1 PIK3C2A PHIP GULP1 | 1.03e-04 | 408 | 168 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | MYH9 SPTBN1 GRIA1 COL25A1 RSBN1 KANSL1 PIK3C2A SEC23IP EPB41L2 CA3 HDLBP GULP1 | 1.13e-04 | 412 | 168 | 12 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | GJD2 ANK3 GRIA1 RABGAP1 NRP2 RSBN1 IGF2BP1 KANSL1 PIK3C2A PHIP HDLBP GULP1 | 1.23e-04 | 416 | 168 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 1.61e-04 | 194 | 168 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | DPYSL2 SFRP2 ANK3 RABGAP1 FAM171B RSBN1 IGF2BP1 KANSL1 PIK3C2A PHIP GULP1 | 1.79e-04 | 369 | 168 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | EDF1 DAPK3 PSMD7 GTF2F2 IGF2BP3 MRPS5 EIF3C PHIP FKBP5 EPB41L2 SYMPK | 2.20e-04 | 378 | 168 | 11 | gudmap_developingGonad_e16.5_testes_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | STXBP4 PKP4 SPTBN1 CHD9 PSMD7 FAM171B ARG1 RSBN1 EXOC5 IGF2BP1 GSDME KANSL1 FUBP1 G3BP2 ARID5B EPB41L2 GULP1 | 2.63e-04 | 815 | 168 | 17 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | MYH9 SFRP2 RYR3 RSBN1 KANSL1 PIK3C2A MAPKAPK3 EPB41L2 CA3 HDLBP GULP1 | 3.06e-04 | 393 | 168 | 11 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | ABCB7 RABGAP1 FAM171B NRP2 RSBN1 IGF2BP1 KANSL1 PIK3C2A PHIP GULP1 | 3.09e-04 | 330 | 168 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | EDF1 DAPK3 PSMD7 IGF2BP1 GTF2F2 IGF2BP3 CIAPIN1 MRPS5 EIF3C PHIP CBX2 SYMPK HDLBP | 3.34e-04 | 533 | 168 | 13 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200 | 3.37e-04 | 164 | 168 | 7 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 3.37e-04 | 164 | 168 | 7 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500 | 3.40e-04 | 117 | 168 | 6 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.73e-04 | 277 | 168 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.06e-07 | 169 | 171 | 8 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.06e-07 | 169 | 171 | 8 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.06e-07 | 169 | 171 | 8 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-07 | 185 | 171 | 8 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | Control-Myeloid-MoAM3,_VCAN|Myeloid / Condition, Lineage and Cell class | 7.80e-06 | 186 | 171 | 7 | 0bf16ac48931b62bb3c33d63ff4279654148e293 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.27e-06 | 191 | 171 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.32e-06 | 126 | 171 | 6 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.06e-05 | 195 | 171 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.17e-05 | 198 | 171 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 171 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 171 | 7 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | ad6f1d4d7f5d7bab2ba2e4fff58c535290065c0e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-05 | 146 | 171 | 6 | deeb2c90a478deac7805e1f0d1466bf5bc42f746 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 159 | 171 | 6 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 159 | 171 | 6 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.48e-05 | 159 | 171 | 6 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.00e-05 | 163 | 171 | 6 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.28e-05 | 165 | 171 | 6 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.28e-05 | 165 | 171 | 6 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.43e-05 | 166 | 171 | 6 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.43e-05 | 166 | 171 | 6 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 4.90e-05 | 169 | 171 | 6 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.23e-05 | 171 | 171 | 6 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 173 | 171 | 6 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 173 | 171 | 6 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.13e-05 | 176 | 171 | 6 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.13e-05 | 176 | 171 | 6 | e08e7a6dd0208acfbb8646d71915af822a64b5de | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.13e-05 | 176 | 171 | 6 | b8264cdda75c5145d8bf8ae00b3e05393fe9a92b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.13e-05 | 176 | 171 | 6 | 4aee9fdada077db7e531684ab938153f84dc8146 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.73e-05 | 179 | 171 | 6 | dfefa4b7ae0ee50cf67e0f1938c682f08a03ec53 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.73e-05 | 179 | 171 | 6 | 64672528f73ac0921f9c7df72e14ecbfac4d5270 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.73e-05 | 179 | 171 | 6 | fa0dd87111d399649cdea55f2e610ebc169e8a56 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-05 | 181 | 171 | 6 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-05 | 182 | 171 | 6 | c4a7007c864a9455a7e7447e28ccd380878a6a0f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-05 | 182 | 171 | 6 | c315d820ffad912c014ba5eac6f5fa6de1a94384 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.84e-05 | 184 | 171 | 6 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-05 | 185 | 171 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.53e-05 | 116 | 171 | 5 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 188 | 171 | 6 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | Influenza_Severe-RBC|World / Disease group and Cell class | 8.82e-05 | 188 | 171 | 6 | f0438e6a77ee1f0456cb65926685266fff470983 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 8.82e-05 | 188 | 171 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 188 | 171 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | facs-SCAT-Fat-3m|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 188 | 171 | 6 | b8dff61240e5052c2fbf7f28b86fe41822df45b0 | |
| ToppCell | facs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-05 | 189 | 171 | 6 | d424d2554595b2304219f7324406b401711af7c2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-05 | 189 | 171 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.09e-05 | 189 | 171 | 6 | fccadf8efbef17b7f12291b069c71060a71b04e2 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-05 | 189 | 171 | 6 | 393ec5954a12d6cf67bb435dcc34ff0b14c81e9f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-05 | 189 | 171 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-05 | 189 | 171 | 6 | bec57459ad4bab15b2532b57722549fec2e771fb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-05 | 190 | 171 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 190 | 171 | 6 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.35e-05 | 190 | 171 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.35e-05 | 190 | 171 | 6 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 191 | 171 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 191 | 171 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 191 | 171 | 6 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 191 | 171 | 6 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.91e-05 | 192 | 171 | 6 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 192 | 171 | 6 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 193 | 171 | 6 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.02e-04 | 193 | 171 | 6 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.02e-04 | 193 | 171 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 1.02e-04 | 193 | 171 | 6 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 194 | 171 | 6 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.05e-04 | 194 | 171 | 6 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | droplet-Fat-Scat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 194 | 171 | 6 | 0f81df418166589ea327d6dfe06674bcf2fe8f72 | |
| ToppCell | droplet-Fat-Scat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 194 | 171 | 6 | 009b005a94a5c80f6e1fdda2a0c7881a9a0ce75b | |
| ToppCell | droplet-Fat-Scat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 194 | 171 | 6 | 84bfe5e68069824370dc2a3f2c5958c552eaaa03 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 195 | 171 | 6 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 196 | 171 | 6 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.11e-04 | 196 | 171 | 6 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.11e-04 | 196 | 171 | 6 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 196 | 171 | 6 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 196 | 171 | 6 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 197 | 171 | 6 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 197 | 171 | 6 | 78bc83cd5546c7dd128e6791acda97f55089bc1c | |
| ToppCell | Influenza_Severe-Classical_Monocyte|World / Disease group and Cell class | 1.14e-04 | 197 | 171 | 6 | e9a01f0fbbeaf6b23bce4603f62053c003848da4 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 197 | 171 | 6 | f45a93b5ad80a16b760acbaa6467648ffc05a0d3 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.14e-04 | 197 | 171 | 6 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 197 | 171 | 6 | 15d1e0dffee8f5ba8cee37adfbfa0551a0cd5e15 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 124 | 171 | 5 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 198 | 171 | 6 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 198 | 171 | 6 | 3ae1e2b4ca77b94eaa24a8c990780aff47dface6 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-04 | 198 | 171 | 6 | 5bdffabf80716dd80c1265c3d126c7a25340251c | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.17e-04 | 198 | 171 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 198 | 171 | 6 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 198 | 171 | 6 | fb70a649e4e2edb32967328c1085dc5999c29a33 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-04 | 198 | 171 | 6 | 00fdee373eaa43c9ce897f2ba2ecbe94cedea93a | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 199 | 171 | 6 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 199 | 171 | 6 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 199 | 171 | 6 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-CD14+_Monocyte|Leuk-UTI / Disease, condition lineage and cell class | 1.24e-04 | 200 | 171 | 6 | 04d0164b80d424a308ada3fea6bb4a9d6cf686e3 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-04 | 200 | 171 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-04 | 200 | 171 | 6 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-04 | 200 | 171 | 6 | f5f24273bee3259a4a3be99ba53b88defa1286c0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.24e-04 | 200 | 171 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 171 | 6 | d237cf947d6768b022d18211e14af4adb4990708 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 7.09e-07 | 4 | 167 | 3 | DOID:0060158 (implicated_via_orthology) | |
| Disease | nervous system disorder | 1.26e-05 | 53 | 167 | 5 | C0027765 | |
| Disease | Colorectal Neoplasms | 3.06e-05 | 277 | 167 | 9 | C0009404 | |
| Disease | Malignant neoplasm of breast | MYH9 SFRP2 ABL1 DYNC2H1 STXBP4 KIF16B ELP1 ABCB6 MAP3K1 HNRNPK ABCB1 ABCB10 CSF3 SURF1 G3BP2 FKBPL CAVIN1 HDLBP | 4.08e-05 | 1074 | 167 | 18 | C0006142 |
| Disease | Drug toxicity | 1.18e-04 | 84 | 167 | 5 | C0013221 | |
| Disease | Adverse reaction to drug | 1.18e-04 | 84 | 167 | 5 | C0041755 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 1.86e-04 | 50 | 167 | 4 | C0023453 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.90e-04 | 4 | 167 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Hyperbilirubinemia | 1.90e-04 | 4 | 167 | 2 | C0020433 | |
| Disease | Mammary Carcinoma, Human | MYH9 SFRP2 ABL1 DYNC2H1 STXBP4 ELP1 MAP3K1 HNRNPK ABCB1 CSF3 FKBPL | 2.13e-04 | 525 | 167 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | MYH9 SFRP2 ABL1 DYNC2H1 STXBP4 ELP1 MAP3K1 HNRNPK ABCB1 CSF3 FKBPL | 2.13e-04 | 525 | 167 | 11 | C1257931 |
| Disease | Childhood Acute Lymphoblastic Leukemia | 2.17e-04 | 52 | 167 | 4 | C0023452 | |
| Disease | Mammary Neoplasms | MYH9 SFRP2 ABL1 DYNC2H1 STXBP4 ELP1 MAP3K1 HNRNPK ABCB1 CSF3 FKBPL | 2.20e-04 | 527 | 167 | 11 | C1458155 |
| Disease | chronic myeloid leukemia (is_implicated_in) | 2.20e-04 | 21 | 167 | 3 | DOID:8552 (is_implicated_in) | |
| Disease | Adenocarcinoma of large intestine | 2.21e-04 | 96 | 167 | 5 | C1319315 | |
| Disease | Intellectual Disability | 2.46e-04 | 447 | 167 | 10 | C3714756 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.53e-04 | 154 | 167 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | Breast Carcinoma | MYH9 SFRP2 ABL1 DYNC2H1 STXBP4 ELP1 MAP3K1 HNRNPK ABCB1 CSF3 FKBPL | 2.62e-04 | 538 | 167 | 11 | C0678222 |
| Disease | status epilepticus (biomarker_via_orthology) | 2.67e-04 | 100 | 167 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 2.70e-04 | 55 | 167 | 4 | DOID:9952 (is_implicated_in) | |
| Disease | fructose-1,6-bisphosphatase isozyme 2 measurement | 3.15e-04 | 5 | 167 | 2 | EFO_0802556 | |
| Disease | body fat percentage, coronary artery disease | 3.30e-04 | 24 | 167 | 3 | EFO_0001645, EFO_0007800 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 4.02e-04 | 61 | 167 | 4 | C1961102 | |
| Disease | Ciliopathies | 4.15e-04 | 110 | 167 | 5 | C4277690 | |
| Disease | Pure gonadal dysgenesis 46,XY | 4.71e-04 | 6 | 167 | 2 | cv:C2936694 | |
| Disease | fructose-1,6-bisphosphatase 1 measurement | 4.71e-04 | 6 | 167 | 2 | EFO_0801606 | |
| Disease | Cone-Rod Dystrophy 2 | 5.84e-04 | 29 | 167 | 3 | C3489532 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.97e-04 | 181 | 167 | 6 | DOID:684 (is_implicated_in) | |
| Disease | Myopathy | 6.46e-04 | 30 | 167 | 3 | C0026848 | |
| Disease | Swyer Syndrome | 6.56e-04 | 7 | 167 | 2 | C2936694 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 8.57e-04 | 33 | 167 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | Gonadal Dysgenesis, 46,XY | 8.72e-04 | 8 | 167 | 2 | C0018054 | |
| Disease | cholestasis (implicated_via_orthology) | 1.12e-03 | 9 | 167 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.17e-03 | 206 | 167 | 6 | C0152013 | |
| Disease | Profound Mental Retardation | 1.19e-03 | 139 | 167 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.19e-03 | 139 | 167 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.19e-03 | 139 | 167 | 5 | C0917816 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.20e-03 | 37 | 167 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | age at menarche, spine bone mineral density | 1.39e-03 | 10 | 167 | 2 | EFO_0004703, EFO_0007701 | |
| Disease | Methylmalonic acidemia | 1.39e-03 | 10 | 167 | 2 | C0268583 | |
| Disease | Hereditary hearing loss and deafness | 1.48e-03 | 146 | 167 | 5 | cv:C0236038 | |
| Disease | Liver Cirrhosis, Experimental | ZFYVE16 ACAT1 PALMD GASK1B ABCB1 IGF2BP3 CSF3 ABCC2 MVP EPB41L2 CA3 GULP1 | 1.58e-03 | 774 | 167 | 12 | C0023893 |
| Disease | Methylmalonic aciduria | 1.69e-03 | 11 | 167 | 2 | C1855119 | |
| Disease | Gastrointestinal Diseases | 2.02e-03 | 12 | 167 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 2.02e-03 | 12 | 167 | 2 | C0559031 | |
| Disease | Cholera Infantum | 2.02e-03 | 12 | 167 | 2 | C1565321 | |
| Disease | mean reticulocyte volume | MYH9 ABCB7 NUP210L STXBP4 NLRX1 IGF2BP2 KANSL1 SEC23IP FLCN ARHGAP21 EPB41L2 HDLBP | 2.06e-03 | 799 | 167 | 12 | EFO_0010701 |
| Disease | Colorectal Carcinoma | DPYSL2 SFRP2 ABCB6 ABCA10 ABCB1 ABCB10 MLH1 FLCN MTRR ABCC2 PHIP | 2.27e-03 | 702 | 167 | 11 | C0009402 |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 2.38e-03 | 13 | 167 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 2.71e-03 | 49 | 167 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | hemoglobin A1 measurement | 2.95e-03 | 520 | 167 | 9 | EFO_0007629 | |
| Disease | QRS-T angle | 3.14e-03 | 106 | 167 | 4 | EFO_0020097 | |
| Disease | Rheumatoid Arthritis | 3.18e-03 | 174 | 167 | 5 | C0003873 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 3.19e-03 | 15 | 167 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 3.19e-03 | 15 | 167 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | fibrinogen measurement | 3.47e-03 | 109 | 167 | 4 | EFO_0004623 | |
| Disease | Peripheral Nervous System Diseases | 3.57e-03 | 54 | 167 | 3 | C4721453 | |
| Disease | Metastatic melanoma | 3.57e-03 | 54 | 167 | 3 | C0278883 | |
| Disease | Ischemic stroke, fibrinogen measurement | 3.76e-03 | 55 | 167 | 3 | EFO_0004623, HP_0002140 | |
| Disease | myocardial infarction | 3.91e-03 | 350 | 167 | 7 | EFO_0000612 | |
| Disease | ulcerative colitis (is_implicated_in) | 4.10e-03 | 17 | 167 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | Polydactyly | 4.47e-03 | 117 | 167 | 4 | C0152427 | |
| Disease | cortical thickness | DPYSL2 NSF NUP210L SPTBN1 RABGAP1 VIT MAP3K1 NRP2 IGF2BP1 KANSL1 MRPL14 C1QTNF1 AGBL2 ARHGAP21 | 4.48e-03 | 1113 | 167 | 14 | EFO_0004840 |
| Disease | caudal middle frontal gyrus volume measurement | 4.59e-03 | 18 | 167 | 2 | EFO_0010290 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 4.59e-03 | 18 | 167 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 5.03e-03 | 121 | 167 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | alkaline phosphatase measurement | WHRN SPTBN1 KIF16B PHEX RSBN1 IGF2BP1 NWD2 KANSL1 C1QTNF1 FUBP3 ARHGAP21 HDLBP MYBPC3 | 5.26e-03 | 1015 | 167 | 13 | EFO_0004533 |
| Disease | number of teeth measurement | 5.66e-03 | 20 | 167 | 2 | EFO_0010073 | |
| Disease | end stage renal disease (implicated_via_orthology) | 5.66e-03 | 20 | 167 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | pars triangularis volume measurement | 5.66e-03 | 20 | 167 | 2 | EFO_0010321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GIEKLVNITKGRGDR | 961 | Q99569 | |
| VKGAQGGLLRKQEEQ | 6 | Q6NS38 | |
| KEALKQRDGIAVIGI | 131 | P07451 | |
| TGQRQIVDKGEAKGI | 1586 | A6H8Y1 | |
| EGKLTAQGKLLGQDT | 346 | Q86VW2 | |
| GSLERQAGQIKKLEV | 126 | Q6NZI2 | |
| GGGKREDKKLQNAIV | 136 | Q9UKL4 | |
| GQKRKLTLGIAILGD | 531 | Q8WWZ4 | |
| LGKVKLNLGGSSRVE | 96 | O60443 | |
| AGVKEGDRIIKVNGT | 81 | O15085 | |
| EKNKQILVLGLDGAG | 16 | Q6T311 | |
| KGLVDKLQALTGNEG | 26 | Q6FI81 | |
| GERGLKLSGGEKQRV | 721 | Q9NP58 | |
| VVGEKGVLLSGGQKQ | 626 | Q9NRK6 | |
| LGLKLGDRVVIAGQK | 281 | Q8N3C7 | |
| LSKIREVAQQGGLKL | 606 | Q569K6 | |
| EVKKNGRISLVLGGD | 86 | P05089 | |
| GVRLKEGGNINKSLV | 266 | Q96L93 | |
| GKLGIIARGDENINV | 1536 | Q9ULI1 | |
| QKIQKLVLEGRVGEA | 296 | Q6VN20 | |
| RQLKIVVLGDGASGK | 11 | P51157 | |
| AGKELKAGELRLQLG | 1116 | Q9H0J4 | |
| DKGTQLSGGQKQRIA | 1171 | P08183 | |
| KTGLKIVGNGSEQQL | 46 | Q9Y3P9 | |
| RGVLKIVKRVGNGEE | 31 | Q13451 | |
| RIKIKTNGLGIGVNE | 286 | Q9NP74 | |
| SVIQRGSGKKELVGE | 676 | Q8IY17 | |
| QKERVGGEERLKGLG | 566 | Q02779 | |
| EGLLVGLKNGQILKI | 486 | Q9HBG6 | |
| SKQVLGLGVNGKVLE | 46 | Q16644 | |
| IIEGAKDGKGRGRQV | 121 | Q9Y295 | |
| TATGAEGKRKLQIGV | 21 | P26885 | |
| GKVRGIIDELQGKAL | 191 | Q8NFG4 | |
| QVELRGRTELKGKGA | 1036 | Q02846 | |
| IGKGGETIKQLQERA | 201 | Q96AE4 | |
| RLLIKGGKIVNDDQS | 16 | Q16555 | |
| RVIGKGGKTVNELQN | 501 | Q9NZI8 | |
| NGGKIIDKRLQELGA | 106 | Q9UBK8 | |
| DGAGKTSLIRKIQGI | 76 | Q9Y6G9 | |
| QLIEGKKNSLRVEGD | 606 | O43491 | |
| KGRQAKGTGELTQLL | 21 | O00757 | |
| EVGKVIQQGRQSKGL | 76 | O60869 | |
| KTKEGLIGLLQEGNT | 101 | P43897 | |
| AKIVVEEGSKNIRLG | 111 | O00330 | |
| KLVQLLGGVAEKVRQ | 1051 | O00443 | |
| LIKRRLIKGDQGQAG | 181 | Q9BXS0 | |
| LVIGRGGETIKQLQE | 176 | Q96I24 | |
| GGETIKQLQERTGVK | 181 | Q96I24 | |
| KTVKGVIIQGARGGD | 496 | O60462 | |
| LKRQAQEEAKGALLG | 391 | O43293 | |
| LEKELSEKSGQLRQG | 981 | Q2M1P5 | |
| KQIRANKGLIVLGEV | 471 | Q7Z3B3 | |
| TGKRQKIEVGLVVGN | 166 | P46459 | |
| TKDQLVGLGRTLAGK | 1041 | O95163 | |
| EKGINLSGGQKQRIS | 756 | Q92887 | |
| RGELANEVKVLLQGK | 1226 | P35579 | |
| AGRVIGKGGKTVNEL | 521 | Q9Y6M1 | |
| QKVGKEVAELVGRVG | 516 | Q86UT6 | |
| ANKIGVGVVRDGKVL | 11 | Q9NPF4 | |
| AGQKIKELLSGIGNI | 451 | Q0VG06 | |
| RVIGKGGKTVNELQN | 501 | O00425 | |
| VGGFGRVELVKVKNE | 461 | Q13237 | |
| DGKNQLGQKRVVKGE | 291 | Q14764 | |
| QRSKESLGEAGIQKG | 151 | Q9BXP8 | |
| GKKGTDRAAQIELLQ | 341 | Q99613 | |
| ESQGGRQGIEKLIDV | 481 | Q6UWH4 | |
| KRIGEELKQAGRKGN | 61 | Q9HDB9 | |
| GRLQEAKLQIKISGL | 4206 | Q8NCM8 | |
| KRSIGTGGIQDLKER | 376 | O00471 | |
| GRESNVGGIQQLSKK | 1336 | Q3L8U1 | |
| LGKVVIQGKNQDAGL | 326 | Q9UIM3 | |
| LGLDLKVRTQKGELG | 286 | Q14781 | |
| QINITILKGEKGDRG | 91 | Q9BXJ1 | |
| NILGGSEELLGKQKQ | 121 | Q8WWF6 | |
| NVVELRINTKGVGGK | 356 | Q9UN86 | |
| LAKLQAQVRIGGKGT | 6 | Q96K17 | |
| GGKDVETRKQIAGLQ | 156 | Q9UBP9 | |
| GKRQLLQEEVGAVGV | 471 | Q86WU2 | |
| KKLERAEQLIGGLGG | 2871 | Q8WXX0 | |
| VEKELGKQGVRGAVS | 506 | P00519 | |
| GKRGIVKELAVTLQG | 246 | Q5U5Z8 | |
| VLGEQQKTKELIGIR | 3846 | Q12955 | |
| DLKELGIKTDGSRQQ | 811 | Q68DC2 | |
| KNVKVTTQGLLDGRG | 341 | P41597 | |
| GSLEVGKQGDLIIIN | 381 | Q96NU7 | |
| GVEEKRGKGNPISIQ | 26 | O75426 | |
| VRKIQGDGAALQEKL | 51 | P09919 | |
| IQLVEGVKRKDQGFL | 6 | Q9Y5P2 | |
| VGVAKKLLQVDGLEN | 151 | Q8N8Q3 | |
| RGKLLQVNTGAKEQL | 1136 | Q05BV3 | |
| RGKGKILVGTRNAEI | 1661 | Q05BV3 | |
| RGAINGEVGDLKQLV | 476 | Q9BXX0 | |
| AKGGRKQALLISEQE | 5896 | Q8NDH2 | |
| DELGGQISVLQRKGI | 211 | Q8N8Z6 | |
| AILGQIIKLEKNGIG | 211 | P42261 | |
| LELSNVGKRKIDQEG | 411 | Q86UP8 | |
| LELSNVGKRKIDQEG | 411 | Q6EKJ0 | |
| QDGKIGLRLKSIDNG | 121 | O00560 | |
| ITIGKVDGLAALQKG | 51 | Q3KQZ1 | |
| GGKELKVNGSIQVSL | 261 | Q6P995 | |
| KQGKAVLLIGEQGTA | 2581 | Q8TE73 | |
| DKQGVFTLLKEGIQR | 596 | Q5VU65 | |
| GDVILKVNGASLKGL | 1551 | Q12923 | |
| KGQAGELAVGREILK | 711 | Q13233 | |
| GLKENGIIILKDNVA | 211 | Q5VVY1 | |
| GRQGREELIKKGLLE | 101 | Q96KR7 | |
| GLVIGKGGETIKQLQ | 246 | Q92945 | |
| KGGETIKQLQERAGV | 251 | Q92945 | |
| GTGQLQEQKKGLLIA | 476 | Q9BVN2 | |
| KQENGERTGGVPLIK | 216 | Q5VWQ0 | |
| KKRKDLNRGQIIGEG | 121 | P82675 | |
| GRGEVGKLRIAKTQG | 36 | P13984 | |
| TGIGKETAKELAQRG | 51 | Q8TC12 | |
| LTEGQVGKLLIRKSG | 321 | P05423 | |
| GQKQGGELVITSVKR | 261 | Q96HF1 | |
| ALEKLDGTEVNGRKI | 156 | Q08170 | |
| QLVRGGQAEKLGEKE | 141 | Q9Y285 | |
| VGKVGDQILLAIKGQ | 66 | Q6P1L8 | |
| LTQKARGKRVGGDVT | 426 | Q15031 | |
| GKGRGVQESKRGLVQ | 466 | Q5JRA6 | |
| IGKVGNQKRVVGVLL | 26 | P51665 | |
| KDLAGSIIGKGGQRI | 396 | P61978 | |
| DINVQLKIGSLEGKR | 16 | Q8NEB9 | |
| SKALQQGLVGLELKE | 96 | P58107 | |
| LKKRAQDAVIILGGG | 6 | Q02127 | |
| GINGIKDARKVTVGV | 21 | Q8NFT2 | |
| VVLKTGLDIGRNKVE | 146 | Q9P0P8 | |
| KLGSIAIQGAIEKAG | 66 | P24752 | |
| LLQGGDEKKVNLVLG | 271 | Q9P202 | |
| TRQKGQIEGEVDLIG | 191 | Q15526 | |
| LGGDATGVDRNIKKI | 506 | Q9Y6Y8 | |
| QQKTLLADKGEIRVG | 156 | Q13330 | |
| VKEGGLKLIQIQDNG | 51 | P40692 | |
| DGKGVVVVIKRRSGQ | 56 | P46779 | |
| AKETGLGLKVLGGIN | 26 | Q6ZWJ1 | |
| GKEINGRKIKLIEGS | 166 | Q13243 | |
| KEGVLEKRSGGLLQL | 11 | Q9Y5J5 | |
| EGKRIGKVLDNAIET | 286 | Q01082 | |
| QVGERGLKLSGGEKQ | 601 | O75027 | |
| GLKLSGGEKQRVAIA | 606 | O75027 | |
| RKKNVVDGRVGLLGN | 186 | Q9NY30 | |
| TEALGRNGQKEALLK | 131 | Q14865 | |
| IVETKGSAGKRNGRV | 61 | Q9UGN4 | |
| RLSQLESQVKGGGDK | 661 | Q16281 | |
| NAKEIVLKAQILAGG | 76 | Q96I99 | |
| LGKGKSIVDVGLAQA | 236 | Q8NCJ5 | |
| GQKVLLEKTGSQLGE | 141 | Q15697 | |
| KQKRLAVGELTENGL | 921 | Q8WWQ0 | |
| VRGLAGVENVTELKK | 16 | P11217 | |
| LQLIKVQEGVGEGKV | 281 | Q9NQ55 | |
| GAQGERLKEATKINL | 256 | O15066 | |
| GGGLVEGAKNIRVTK | 4216 | Q15413 | |
| LESIRQAGGIGKAKL | 366 | Q6VEQ5 | |
| VSEVELGGNGLKRTK | 911 | O94964 | |
| LESIRQAGGIGKAKL | 366 | A8K0Z3 | |
| DNSGGKILVRKVAGQ | 96 | Q6UXI7 | |
| AEGQGQGQLLIKTVK | 801 | Q5SRE5 | |
| GLNVKGKRTLGENIA | 631 | P78562 | |
| AVEGKRIGKVLDQVL | 291 | Q9H254 | |
| NIKRGESGNIKAGLE | 161 | Q96IZ7 | |
| RQLEEEQKLKPGGVG | 1151 | Q92797 | |
| EEAEQLALKGGKRTI | 961 | Q9H6N6 | |
| ARIKSKLDQGGVIQD | 3556 | P78527 | |
| VEGKVVRLGQGIGKS | 31 | Q86TA4 | |
| KAGAKAGRQGEITIL | 331 | Q969Z4 | |
| GNLEGEARKTKVQLA | 821 | Q9UI33 | |
| LQKGEGVRVLGKCQD | 401 | Q8TEC5 | |
| KDGKERLGGSVLGQI | 251 | Q9NRL3 | |
| AVKREQLKNGGLGVV | 281 | P10827 | |
| IIGKGGANIKKIREE | 596 | Q00341 | |
| FLEQLGGEVGTQRKK | 101 | Q53EQ6 | |
| GIRGTNIVVLGVEKK | 36 | Q8TAA3 | |
| GDRIIKVNGESVIGK | 121 | Q5T5U3 | |
| GTKEKGGRRDLQIKV | 581 | Q9H091 | |
| DQGLKKILEVGGSLQ | 341 | Q9H3U1 | |
| LQNREIGGIKELGIK | 196 | Q7Z3T8 | |
| GSILKGVLKVGQEIE | 281 | P41091 | |
| GGQALAELIVQEKKL | 531 | Q14896 |